JP2021506889A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021506889A5 JP2021506889A5 JP2020534224A JP2020534224A JP2021506889A5 JP 2021506889 A5 JP2021506889 A5 JP 2021506889A5 JP 2020534224 A JP2020534224 A JP 2020534224A JP 2020534224 A JP2020534224 A JP 2020534224A JP 2021506889 A5 JP2021506889 A5 JP 2021506889A5
- Authority
- JP
- Japan
- Prior art keywords
- indole
- isopropyl
- triazolo
- pyridin
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 dimethylpyrazolyl Chemical group 0.000 claims 108
- 125000000217 alkyl group Chemical group 0.000 claims 36
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 34
- 125000003386 piperidinyl group Chemical group 0.000 claims 22
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 21
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 19
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 19
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 17
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 15
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims 14
- 125000003545 alkoxy group Chemical group 0.000 claims 13
- 125000002757 morpholinyl group Chemical group 0.000 claims 13
- 125000002393 azetidinyl group Chemical group 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 11
- 125000000168 pyrrolyl group Chemical group 0.000 claims 11
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 10
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- 125000004103 aminoalkyl group Chemical group 0.000 claims 9
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 9
- 125000004193 piperazinyl group Chemical group 0.000 claims 9
- 229910052799 carbon Inorganic materials 0.000 claims 8
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 8
- 150000001204 N-oxides Chemical class 0.000 claims 7
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 7
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims 6
- 125000004966 cyanoalkyl group Chemical group 0.000 claims 6
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 125000003566 oxetanyl group Chemical group 0.000 claims 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 5
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 5
- 125000004076 pyridyl group Chemical group 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 5
- SODPIVPXQHNCES-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-3-ethyl-5-[(5-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-2-yl)methyl]-1H-indole Chemical compound COC=1C=C(C=CC=1OC)C=1NC2=CC=C(C=C2C=1CC)CN1CC2CN(CC2C1)C(C)C SODPIVPXQHNCES-UHFFFAOYSA-N 0.000 claims 4
- QBZLCMRAAJXEFT-UHFFFAOYSA-N 2-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]morpholine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CNCCO1)C1=CN2N=CN=C2C(C)=C1 QBZLCMRAAJXEFT-UHFFFAOYSA-N 0.000 claims 4
- XOKYECLXCBVFTK-UHFFFAOYSA-N 4-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]-N,N-dimethylcyclohexan-1-amine Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)N(C)C)C XOKYECLXCBVFTK-UHFFFAOYSA-N 0.000 claims 4
- NUDZXOZPZDHDEZ-UHFFFAOYSA-N 4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-(2-methoxyethyl)-N-methylcyclohexan-1-amine Chemical compound COCCN(C)C1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1C NUDZXOZPZDHDEZ-UHFFFAOYSA-N 0.000 claims 4
- TZBNVVMCKPEJCV-UHFFFAOYSA-N 4-[4-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]morpholine Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)N1CCOCC1)C TZBNVVMCKPEJCV-UHFFFAOYSA-N 0.000 claims 4
- PZWVCAIXLAZPQL-UHFFFAOYSA-N 6-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]-2-oxa-6-azaspiro[3.3]heptane Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)N1CC2(COC2)C1)C1=CN2N=CN=C2C(C)=C1C PZWVCAIXLAZPQL-UHFFFAOYSA-N 0.000 claims 4
- VYIOQCZAMSOEJW-UHFFFAOYSA-N 8-methoxy-6-(5-piperidin-3-yl-3-propan-2-yl-1H-indol-2-yl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCCNC1 VYIOQCZAMSOEJW-UHFFFAOYSA-N 0.000 claims 4
- QGJGTRNASJZNRX-UHFFFAOYSA-N 8-methoxy-6-[5-[1-(2-methoxyethyl)piperidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(CCC1)CCOC)C=1C=C(C=2N(C=1)N=CN=2)OC QGJGTRNASJZNRX-UHFFFAOYSA-N 0.000 claims 4
- HFLQCFDNDYNLFO-UHFFFAOYSA-N 8-methoxy-6-[5-[1-(oxan-4-yl)piperidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(CCC1)C1CCOCC1)C=1C=C(C=2N(C=1)N=CN=2)OC HFLQCFDNDYNLFO-UHFFFAOYSA-N 0.000 claims 4
- WKNWULRFPOTOTI-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(C)(C)O)CCO1)C1=CN2N=CN=C2C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(C)(C)O)CCO1)C1=CN2N=CN=C2C(C)=C1 WKNWULRFPOTOTI-UHFFFAOYSA-N 0.000 claims 4
- YTBMNQANUJHMIP-UHFFFAOYSA-N N-cyclopropyl-N-methyl-4-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound C1(CC1)N(C1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C=2N(C=1)N=CN=2)C)C(C)C)C YTBMNQANUJHMIP-UHFFFAOYSA-N 0.000 claims 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- 125000003725 azepanyl group Chemical group 0.000 claims 4
- 125000002883 imidazolyl group Chemical group 0.000 claims 4
- 125000001425 triazolyl group Chemical group 0.000 claims 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 3
- QJVZBCGQTBXKDN-UHFFFAOYSA-N 6-[4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]-2-oxa-6-azaspiro[3.3]heptane Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)N1CC2(COC2)C1 QJVZBCGQTBXKDN-UHFFFAOYSA-N 0.000 claims 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- YFFRSVFAPFSHAS-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1OCCN(C1)CC(=O)N(C)C)C=1C=C(C=2N(C=1)N=CN=2)C Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1OCCN(C1)CC(=O)N(C)C)C=1C=C(C=2N(C=1)N=CN=2)C YFFRSVFAPFSHAS-UHFFFAOYSA-N 0.000 claims 3
- 125000005959 diazepanyl group Chemical group 0.000 claims 3
- 125000005879 dioxolanyl group Chemical group 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 125000001475 halogen functional group Chemical group 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 claims 3
- PCSYHKIAVUEBHT-UHFFFAOYSA-N 1,3,4-trimethyl-5-[3-propan-2-yl-5-(1-propan-2-ylazetidin-3-yl)-1H-indol-2-yl]pyridin-2-one Chemical compound CC(C)N1CC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1C PCSYHKIAVUEBHT-UHFFFAOYSA-N 0.000 claims 2
- BJLMHPCVKKAWFD-UHFFFAOYSA-N 1,3,4-trimethyl-5-[3-propan-2-yl-5-(1-propylazetidin-3-yl)-1H-indol-2-yl]pyridin-2-one Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)CCC)C=1C(=C(C(N(C=1)C)=O)C)C BJLMHPCVKKAWFD-UHFFFAOYSA-N 0.000 claims 2
- YHLSHOGYEPQXDT-UHFFFAOYSA-N 1,3,4-trimethyl-5-[5-[1-(2-methylsulfonylethyl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]pyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CCS(C)(=O)=O)C1)C1=CN(C)C(=O)C(C)=C1C YHLSHOGYEPQXDT-UHFFFAOYSA-N 0.000 claims 2
- WSTCVNGXZWVKHI-UHFFFAOYSA-N 1,3,4-trimethyl-5-[5-[1-(oxetan-3-yl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]pyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)C1COC1)C1=CN(C)C(=O)C(C)=C1C WSTCVNGXZWVKHI-UHFFFAOYSA-N 0.000 claims 2
- INDGTJREMNSNGZ-UHFFFAOYSA-N 1,3,4-trimethyl-5-[5-[3-(2-methylsulfonylethylamino)cyclobutyl]-3-propan-2-yl-1H-indol-2-yl]pyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CC(C1)NCCS(C)(=O)=O)C1=CN(C)C(=O)C(C)=C1C INDGTJREMNSNGZ-UHFFFAOYSA-N 0.000 claims 2
- JRKTVICNVCYIQC-UHFFFAOYSA-N 1,3,4-trimethyl-5-[5-[3-(oxetan-3-ylamino)cyclobutyl]-3-propan-2-yl-1H-indol-2-yl]pyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CC(C1)NC1COC1)C1=CN(C)C(=O)C(C)=C1C JRKTVICNVCYIQC-UHFFFAOYSA-N 0.000 claims 2
- LFFZERJKNCCMJS-UHFFFAOYSA-N 1,3,4-trimethyl-5-[5-[[1-(2-methylsulfonylethyl)azetidin-3-yl]methyl]-3-propan-2-yl-1H-indol-2-yl]pyridin-2-one Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CC1CN(C1)CCS(=O)(=O)C)C=1C(=C(C(N(C=1)C)=O)C)C LFFZERJKNCCMJS-UHFFFAOYSA-N 0.000 claims 2
- ZAQDPINAZOHKBQ-UHFFFAOYSA-N 1,3,4-trimethyl-5-[5-[[1-(oxan-4-yl)azetidin-3-yl]methyl]-3-propan-2-yl-1H-indol-2-yl]pyridin-2-one Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CC1CN(C1)C1CCOCC1)C=1C(=C(C(N(C=1)C)=O)C)C ZAQDPINAZOHKBQ-UHFFFAOYSA-N 0.000 claims 2
- VHFSGXKAPLKPQN-UHFFFAOYSA-N 1,3-dimethyl-5-[3-propan-2-yl-5-(2-pyrrolidin-1-ylethyl)-1H-indol-2-yl]pyridin-2-one Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CCN1CCCC1)C=1C=C(C(N(C=1)C)=O)C VHFSGXKAPLKPQN-UHFFFAOYSA-N 0.000 claims 2
- QJJZAYWNSXDWJI-UHFFFAOYSA-N 1,3-dimethyl-5-[5-(2-piperidin-1-ylethyl)-3-propan-2-yl-1H-indol-2-yl]pyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(CCN3CCCCC3)C=C12)C1=CN(C)C(=O)C(C)=C1 QJJZAYWNSXDWJI-UHFFFAOYSA-N 0.000 claims 2
- UHQVMXQKQIMQLP-UHFFFAOYSA-N 1-[3-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-2,2-dimethylpropan-1-one Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCCN(C1)C(=O)C(C)(C)C)C1=CC(C)=NC(C)=C1 UHQVMXQKQIMQLP-UHFFFAOYSA-N 0.000 claims 2
- DAYASGQXGZKJMZ-UHFFFAOYSA-N 1-[3-[2-(3,4-dimethoxyphenyl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-2-(dimethylamino)ethanone Chemical compound COC1=C(OC)C=C(C=C1)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCCN(C1)C(=O)CN(C)C DAYASGQXGZKJMZ-UHFFFAOYSA-N 0.000 claims 2
- VNTWGQWGNHBFOW-UHFFFAOYSA-N 1-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]azetidin-1-yl]-2-methylpropan-2-ol Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(C)(C)O)C1)C1=CN2N=CN=C2C(C)=C1C VNTWGQWGNHBFOW-UHFFFAOYSA-N 0.000 claims 2
- XTPZRSQZNNBEKR-UHFFFAOYSA-N 1-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-2-(methylamino)ethanone Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CN(CCC1)C(CNC)=O)N=CN=2)C XTPZRSQZNNBEKR-UHFFFAOYSA-N 0.000 claims 2
- YIWCWEBEKKVRJX-UHFFFAOYSA-N 1-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-2-methylpropan-2-ol Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCCN(CC(C)(C)O)C1)C1=CN2N=CN=C2C(C)=C1C YIWCWEBEKKVRJX-UHFFFAOYSA-N 0.000 claims 2
- RNXRXOVQESUXEA-UHFFFAOYSA-N 1-[4-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]-N,N-dimethylmethanamine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CN(C)C)CC1)C1=CC(C)=NC(C)=C1 RNXRXOVQESUXEA-UHFFFAOYSA-N 0.000 claims 2
- YBHKHDNPCSSSIM-UHFFFAOYSA-N 1-[[4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]amino]-2-methylpropan-2-ol Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)NCC(C)(C)O YBHKHDNPCSSSIM-UHFFFAOYSA-N 0.000 claims 2
- KRVDQEBMDKQSPQ-UHFFFAOYSA-N 2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-5-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-3-yl]-1H-indole Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCC1)C1CCN(CC1)C(C)C)C KRVDQEBMDKQSPQ-UHFFFAOYSA-N 0.000 claims 2
- MUPANLIKWABJHF-UHFFFAOYSA-N 2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-5-pyrrolidin-3-yl-1H-indole Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CNCC1)C MUPANLIKWABJHF-UHFFFAOYSA-N 0.000 claims 2
- UVWOHXLOQZSQBT-UHFFFAOYSA-N 2-(2,6-dimethylpyridin-4-yl)-5-[1-[(2-methyl-1H-imidazol-5-yl)methyl]piperidin-3-yl]-3-propan-2-yl-1H-indole Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCC1)CC=1N=C(NC=1)C)C UVWOHXLOQZSQBT-UHFFFAOYSA-N 0.000 claims 2
- FTTGBFKIKPBRMQ-UHFFFAOYSA-N 2-(2,6-dimethylpyridin-4-yl)-5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-3-propan-2-yl-1H-indole Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)N1CCN(CC1)C)C FTTGBFKIKPBRMQ-UHFFFAOYSA-N 0.000 claims 2
- INHPLFJOPMVAFV-UHFFFAOYSA-N 2-(2,6-dimethylpyridin-4-yl)-5-piperidin-3-yl-3-propan-2-yl-1H-indole Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CNCCC1)C INHPLFJOPMVAFV-UHFFFAOYSA-N 0.000 claims 2
- NIAVPSJBCJWMFR-SFTDATJTSA-N 2-(2-methylpyridin-4-yl)-3-propan-2-yl-5-[(1R,2R)-2-(pyrrolidin-1-ylmethyl)cyclopropyl]-1H-indole Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)[C@H]1[C@@H](C1)CN1CCCC1)C1=CC(=NC=C1)C NIAVPSJBCJWMFR-SFTDATJTSA-N 0.000 claims 2
- WZWQUOYRGVIDGL-UHFFFAOYSA-N 2-(2-methylpyridin-4-yl)-5-(4-piperidin-4-yloxycyclohexyl)-3-propan-2-yl-1H-indole Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)OC1CCNCC1)C1=CC(=NC=C1)C WZWQUOYRGVIDGL-UHFFFAOYSA-N 0.000 claims 2
- JSEWNOGKPSBKHQ-UHFFFAOYSA-N 2-(2-methylpyridin-4-yl)-5-piperidin-3-yl-3-propan-2-yl-1H-indole Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CNCCC1)C1=CC(=NC=C1)C JSEWNOGKPSBKHQ-UHFFFAOYSA-N 0.000 claims 2
- AHUPVZJVRLAAOJ-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-3-ethyl-5-(pyrrolidin-2-ylmethyl)-1H-indole Chemical compound COC=1C=C(C=CC=1OC)C=1NC2=CC=C(C=C2C=1CC)CC1NCCC1 AHUPVZJVRLAAOJ-UHFFFAOYSA-N 0.000 claims 2
- STNRNSHLNYITKN-UHFFFAOYSA-N 2-(dimethylamino)-1-[3-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]pyrrolidin-1-yl]ethanone Chemical compound CN(CC(=O)N1CC(CC1)C=1C=C2C(=C(NC2=CC=1)C1=CC(=NC(=C1)C)C)C(C)C)C STNRNSHLNYITKN-UHFFFAOYSA-N 0.000 claims 2
- BRLWUBRWCRIGCO-UHFFFAOYSA-N 2-(dimethylamino)-1-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]azetidin-1-yl]ethanone Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)C(=O)CN(C)C)C1=CN2N=CN=C2C(C)=C1C BRLWUBRWCRIGCO-UHFFFAOYSA-N 0.000 claims 2
- MZHJOWNENJPQDO-UHFFFAOYSA-N 2-(dimethylamino)-1-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]ethanone Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCCN(C1)C(=O)CN(C)C)C1=CN2N=CN=C2C(C)=C1C MZHJOWNENJPQDO-UHFFFAOYSA-N 0.000 claims 2
- XUIRREMJZHMORH-UHFFFAOYSA-N 2-(dimethylamino)-1-[3-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]ethanone Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCCN(C1)C(=O)CN(C)C XUIRREMJZHMORH-UHFFFAOYSA-N 0.000 claims 2
- CUNFXLDCFONNDL-UHFFFAOYSA-N 2-(dimethylamino)-1-[3-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]azetidin-1-yl]ethanone Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)C(=O)CN(C)C)C1=CN2N=CN=C2C(C)=C1 CUNFXLDCFONNDL-UHFFFAOYSA-N 0.000 claims 2
- AYEXYFZEHSEWSK-UHFFFAOYSA-N 2-(dimethylamino)-1-[5-[2-(7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]ethanone Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CC3C(CN(C3)C(CN(C)C)=O)C1)C=NN=2)C AYEXYFZEHSEWSK-UHFFFAOYSA-N 0.000 claims 2
- CSFIZLJOLBBTOQ-UHFFFAOYSA-N 2-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]-4-(oxetan-3-yl)morpholine Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCO1)C1COC1)C CSFIZLJOLBBTOQ-UHFFFAOYSA-N 0.000 claims 2
- UEUBCIVNFDKRLR-UHFFFAOYSA-N 2-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-4-(2-methylsulfonylethyl)morpholine Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CN(CCO1)CCS(=O)(=O)C)N=CN=2)C UEUBCIVNFDKRLR-UHFFFAOYSA-N 0.000 claims 2
- NVMASXPSNIEBSK-UHFFFAOYSA-N 2-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-5,5-dimethylmorpholine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CNC(C)(C)CO1)C1=CN2N=CN=C2C(C)=C1C NVMASXPSNIEBSK-UHFFFAOYSA-N 0.000 claims 2
- RVOBUITVERWCNF-UHFFFAOYSA-N 2-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-4,5,5-trimethylmorpholine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CN(C)C(C)(C)CO1 RVOBUITVERWCNF-UHFFFAOYSA-N 0.000 claims 2
- MCWMHEYQHCAUNQ-UHFFFAOYSA-N 2-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-5,5-dimethyl-4-(oxetan-3-yl)morpholine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CN(C2COC2)C(C)(C)CO1 MCWMHEYQHCAUNQ-UHFFFAOYSA-N 0.000 claims 2
- WCAFZXNQMVYVOD-UHFFFAOYSA-N 2-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-5,5-dimethylmorpholine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CNC(C)(C)CO1 WCAFZXNQMVYVOD-UHFFFAOYSA-N 0.000 claims 2
- KNQKJBGYCZSCNM-UHFFFAOYSA-N 2-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]morpholine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CNCCO1 KNQKJBGYCZSCNM-UHFFFAOYSA-N 0.000 claims 2
- BUHVCIYLAOXRKS-UHFFFAOYSA-N 2-[3-[2-(3,4-dimethoxyphenyl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-N,N-dimethylacetamide Chemical compound COC=1C=C(C=CC=1OC)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCC1)CC(=O)N(C)C BUHVCIYLAOXRKS-UHFFFAOYSA-N 0.000 claims 2
- YIVWVEHXSPYPHT-UHFFFAOYSA-N 2-[3-[2-(3,4-dimethoxyphenyl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-N-methylethanamine Chemical compound COC=1C=C(C=CC=1OC)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCC1)CCNC YIVWVEHXSPYPHT-UHFFFAOYSA-N 0.000 claims 2
- WDOQPCZMXDSOPC-UHFFFAOYSA-N 2-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]azetidin-1-yl]-N,N-dimethylacetamide Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CN(C1)CC(=O)N(C)C)N=CN=2)C WDOQPCZMXDSOPC-UHFFFAOYSA-N 0.000 claims 2
- MGMICNHCPVHNMX-UHFFFAOYSA-N 2-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]azetidin-1-yl]-N-methylacetamide Chemical compound CNC(=O)CN1CC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1C MGMICNHCPVHNMX-UHFFFAOYSA-N 0.000 claims 2
- WQLHTGAPJXLCEH-UHFFFAOYSA-N 2-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]azetidin-1-yl]acetonitrile Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CN(C1)CC#N)N=CN=2)C WQLHTGAPJXLCEH-UHFFFAOYSA-N 0.000 claims 2
- CJLJFGPQZGIZTL-UHFFFAOYSA-N 2-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-N-methylacetamide Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CN(CCC1)CC(=O)NC)N=CN=2)C CJLJFGPQZGIZTL-UHFFFAOYSA-N 0.000 claims 2
- DUKAXUVQAWKNBH-UHFFFAOYSA-N 2-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]azetidin-1-yl]-N,N-dimethylacetamide Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(=O)N(C)C)C1)C1=CN2C=NN=C2C(C)=C1C DUKAXUVQAWKNBH-UHFFFAOYSA-N 0.000 claims 2
- IDSKCFSCVBCTSK-UHFFFAOYSA-N 2-[3-[[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]methyl]azetidin-1-yl]-N,N-dimethylacetamide Chemical compound CC(C)C1=C(NC2=CC=C(CC3CN(CC(=O)N(C)C)C3)C=C12)C1=CN2N=CN=C2C(C)=C1C IDSKCFSCVBCTSK-UHFFFAOYSA-N 0.000 claims 2
- IQGJXVODVCTICI-UHFFFAOYSA-N 2-[3-[[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]methyl]azetidin-1-yl]acetonitrile Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CC1CN(C1)CC#N)C=1C=C(C=2N(C=1)N=CN=2)OC IQGJXVODVCTICI-UHFFFAOYSA-N 0.000 claims 2
- YDCWJLVWMMYRHF-UHFFFAOYSA-N 2-[5-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-N,N-dimethylacetamide Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CC3C(CN(C3)CC(=O)N(C)C)C1)N=CN=2)C YDCWJLVWMMYRHF-UHFFFAOYSA-N 0.000 claims 2
- QKADUGXDWCKYMA-UHFFFAOYSA-N 2-[5-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-N-methylacetamide Chemical compound CNC(=O)CN1CC2CC(CC2C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1C QKADUGXDWCKYMA-UHFFFAOYSA-N 0.000 claims 2
- KAMNMXTWYPOONM-UHFFFAOYSA-N 2-[5-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]acetonitrile Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CC3C(CN(C3)CC#N)C1)N=CN=2)C KAMNMXTWYPOONM-UHFFFAOYSA-N 0.000 claims 2
- SCPKWEWDDJAWKA-UHFFFAOYSA-N 2-[5-[2-(7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-N,N-dimethylacetamide Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CC3C(CN(C3)CC(=O)N(C)C)C1)C=NN=2)C SCPKWEWDDJAWKA-UHFFFAOYSA-N 0.000 claims 2
- QZZKXCPXGVPSRB-UHFFFAOYSA-N 2-[5-[2-(7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]acetonitrile Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CC3C(CN(C3)CC#N)C1)C=NN=2)C QZZKXCPXGVPSRB-UHFFFAOYSA-N 0.000 claims 2
- BGNUFCFEWPJXBS-UHFFFAOYSA-N 2-[5-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-N,N-dimethylacetamide Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CC2C(CN(C2)CC(=O)N(C)C)C1)C=1C=C(C=2N(C=1)N=CN=2)OC BGNUFCFEWPJXBS-UHFFFAOYSA-N 0.000 claims 2
- VIHUJUCOJBIEPL-UHFFFAOYSA-N 2-[[3-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclobutyl]amino]-N,N-dimethylacetamide Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CC(C1)NCC(=O)N(C)C)C=1C=C(C=2N(C=1)N=CN=2)OC VIHUJUCOJBIEPL-UHFFFAOYSA-N 0.000 claims 2
- COFASVKTPJBVEA-UHFFFAOYSA-N 2-[[4-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]amino]-N-methylacetamide Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)NCC(=O)NC)C COFASVKTPJBVEA-UHFFFAOYSA-N 0.000 claims 2
- ULUOLOWRJAVQJP-UHFFFAOYSA-N 2-[[4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]amino]-N-methylacetamide Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NCC(=O)NC)C=1C=C(C=2N(C=1)N=CN=2)OC ULUOLOWRJAVQJP-UHFFFAOYSA-N 0.000 claims 2
- YXTYHSLVCWVESC-UHFFFAOYSA-N 2-methyl-1-[[4-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]amino]propan-2-ol Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NCC(C)(C)O)C1=CN2N=CN=C2C(C)=C1 YXTYHSLVCWVESC-UHFFFAOYSA-N 0.000 claims 2
- SBIKATSJZZOZQH-UHFFFAOYSA-N 3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N,N-dimethylcyclobutan-1-amine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CC(C1)N(C)C)C1=CN2N=CN=C2C(C)=C1C SBIKATSJZZOZQH-UHFFFAOYSA-N 0.000 claims 2
- MGYLVKOMFUMQBE-UHFFFAOYSA-N 3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-(2-methylsulfonylethyl)cyclobutan-1-amine Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CC(C1)NCCS(=O)(=O)C)N=CN=2)C MGYLVKOMFUMQBE-UHFFFAOYSA-N 0.000 claims 2
- DEMXTDYPKZRCSP-UHFFFAOYSA-N 3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclobutan-1-amine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CC(N)C1)C1=CN2N=CN=C2C(C)=C1C DEMXTDYPKZRCSP-UHFFFAOYSA-N 0.000 claims 2
- GIYFRWSZZSTBPD-UHFFFAOYSA-N 3-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N,N-dimethylcyclobutan-1-amine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CC(C1)N(C)C)C=1C=C(C=2N(C=1)N=CN=2)OC GIYFRWSZZSTBPD-UHFFFAOYSA-N 0.000 claims 2
- XYRRULVEBZGGML-UHFFFAOYSA-N 3-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methyl-N-propan-2-ylcyclopentan-1-amine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(C1)N(C)C(C)C XYRRULVEBZGGML-UHFFFAOYSA-N 0.000 claims 2
- UVXIBASXINBGMX-UHFFFAOYSA-N 3-chloro-1,4-dimethyl-5-[3-propan-2-yl-5-(1-propylazetidin-3-yl)-1H-indol-2-yl]pyridin-2-one Chemical compound ClC=1C(N(C=C(C=1C)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(C1)CCC)C)=O UVXIBASXINBGMX-UHFFFAOYSA-N 0.000 claims 2
- UESVQISBAQJRPZ-UHFFFAOYSA-N 3-chloro-1,4-dimethyl-5-[5-[1-(oxolan-3-ylmethyl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]pyridin-2-one Chemical compound ClC=1C(N(C=C(C=1C)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(C1)CC1COCC1)C)=O UESVQISBAQJRPZ-UHFFFAOYSA-N 0.000 claims 2
- WKLCUJKPKKHZLU-UHFFFAOYSA-N 3-ethyl-2-(2-methylpyridin-4-yl)-5-(pyrrolidin-2-ylmethyl)-1H-indole Chemical compound C(C)C1=C(NC2=CC=C(C=C12)CC1NCCC1)C1=CC(=NC=C1)C WKLCUJKPKKHZLU-UHFFFAOYSA-N 0.000 claims 2
- HWIWCCDFYCWEGD-UHFFFAOYSA-N 3-methyl-N-[4-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]oxetan-3-amine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NC1(COC1)C)C=1C=C(C=2N(C=1)N=CN=2)C HWIWCCDFYCWEGD-UHFFFAOYSA-N 0.000 claims 2
- NQVWMPOQWBDSAI-UHFFFAOYSA-N 3-methyloxetan-3-amine Chemical compound CC1(N)COC1 NQVWMPOQWBDSAI-UHFFFAOYSA-N 0.000 claims 2
- WHRHTSKMHVTWSL-UHFFFAOYSA-N 4,5,5-trimethyl-2-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]morpholine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(C)C(C)(C)CO1)C1=CN2N=CN=C2C(C)=C1 WHRHTSKMHVTWSL-UHFFFAOYSA-N 0.000 claims 2
- KETXJLUIWNSGDJ-UHFFFAOYSA-N 4-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]-1-(trifluoromethyl)cyclohexan-1-ol Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)(O)C(F)(F)F)C KETXJLUIWNSGDJ-UHFFFAOYSA-N 0.000 claims 2
- WDLVKCLQVOZKQV-UHFFFAOYSA-N 4-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]-N-[(4-methoxyphenyl)methyl]cyclohexan-1-amine Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)NCC1=CC=C(C=C1)OC)C WDLVKCLQVOZKQV-UHFFFAOYSA-N 0.000 claims 2
- IDZSYRSXOGPDKA-UHFFFAOYSA-N 4-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methylcyclohexan-1-amine Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)NC)C IDZSYRSXOGPDKA-UHFFFAOYSA-N 0.000 claims 2
- ZSDOVNPASSZBPJ-UHFFFAOYSA-N 4-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)N)C ZSDOVNPASSZBPJ-UHFFFAOYSA-N 0.000 claims 2
- VYDRNZWWACMIGI-UHFFFAOYSA-N 4-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-ol Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)O)C VYDRNZWWACMIGI-UHFFFAOYSA-N 0.000 claims 2
- GLGFHSIRUSWQOP-UHFFFAOYSA-N 4-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-one Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)=O)C GLGFHSIRUSWQOP-UHFFFAOYSA-N 0.000 claims 2
- OWQALSHFGFHWNT-UHFFFAOYSA-N 4-[2-(2-methylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-ol Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)O)C1=CC(=NC=C1)C OWQALSHFGFHWNT-UHFFFAOYSA-N 0.000 claims 2
- PIZQRKXUPBZLSG-UHFFFAOYSA-N 4-[2-(3,4-dimethoxyphenyl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound COC=1C=C(C=CC=1OC)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)N PIZQRKXUPBZLSG-UHFFFAOYSA-N 0.000 claims 2
- ZIBKTCVZFPGFOL-UHFFFAOYSA-N 4-[2-(3,4-dimethoxyphenyl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-ol Chemical compound COC=1C=C(C=CC=1OC)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)O ZIBKTCVZFPGFOL-UHFFFAOYSA-N 0.000 claims 2
- KPLMFWXPXBJEAG-UHFFFAOYSA-N 4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-ethyl-N-methylcyclohexan-1-amine Chemical compound CCN(C)C1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1C KPLMFWXPXBJEAG-UHFFFAOYSA-N 0.000 claims 2
- YAFWDGHOQFGZJU-UHFFFAOYSA-N 4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methyl-N-(2-methylsulfonylethyl)cyclohexan-1-amine Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CCC(CC1)N(CCS(=O)(=O)C)C)N=CN=2)C YAFWDGHOQFGZJU-UHFFFAOYSA-N 0.000 claims 2
- RHTQILIYHRUXJI-UHFFFAOYSA-N 4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methylcyclohexan-1-amine Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CCC(CC1)NC)N=CN=2)C RHTQILIYHRUXJI-UHFFFAOYSA-N 0.000 claims 2
- LMORXPWBMRIKNK-UHFFFAOYSA-N 4-[2-(7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(N)CC1)C1=CN2C=NN=C2C(C)=C1C LMORXPWBMRIKNK-UHFFFAOYSA-N 0.000 claims 2
- KTRGIAGCHXDPRA-UHFFFAOYSA-N 4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-(1-methylcyclopropyl)cyclohexan-1-amine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NC1(CC1)C)C=1C=C(C=2N(C=1)N=CN=2)OC KTRGIAGCHXDPRA-UHFFFAOYSA-N 0.000 claims 2
- SDCIULZNONADQG-UHFFFAOYSA-N 4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methyl-N-(2-methylsulfonylethyl)cyclohexan-1-amine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)N(C)CCS(C)(=O)=O SDCIULZNONADQG-UHFFFAOYSA-N 0.000 claims 2
- AHMJRWRNUDOOID-UHFFFAOYSA-N 4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methyl-N-(3,3,3-trifluoropropyl)cyclohexan-1-amine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)N(C)CCC(F)(F)F AHMJRWRNUDOOID-UHFFFAOYSA-N 0.000 claims 2
- ZTUBEQKFZDKPRA-UHFFFAOYSA-N 4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methyl-N-propan-2-ylcyclohexan-1-amine Chemical compound C(C)(C)N(C1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C=2N(C=1)N=CN=2)OC)C(C)C)C ZTUBEQKFZDKPRA-UHFFFAOYSA-N 0.000 claims 2
- UVXQKXGFQKIFIN-UHFFFAOYSA-N 4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methylcyclohexan-1-amine Chemical compound CNC1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(OC)=C1 UVXQKXGFQKIFIN-UHFFFAOYSA-N 0.000 claims 2
- HVDBIFIEJUXPSR-UHFFFAOYSA-N 4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(N)CC1 HVDBIFIEJUXPSR-UHFFFAOYSA-N 0.000 claims 2
- VOEMJWGAMXOHEP-UHFFFAOYSA-N 4-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(N)CC1)C1=CN2N=CN=C2C(C)=C1 VOEMJWGAMXOHEP-UHFFFAOYSA-N 0.000 claims 2
- BLAQBNDCAHEFPU-UHFFFAOYSA-N 4-[2-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]ethyl]-1,4-thiazinane 1,1-dioxide Chemical compound CC(C)C1=C(NC2=CC=C(CCN3CCS(=O)(=O)CC3)C=C12)C1=CC(C)=NC(C)=C1 BLAQBNDCAHEFPU-UHFFFAOYSA-N 0.000 claims 2
- YOOGDLWVSZPXAN-UHFFFAOYSA-N 4-[2-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]ethyl]morpholine Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)CCN1CCOCC1)C YOOGDLWVSZPXAN-UHFFFAOYSA-N 0.000 claims 2
- BPSIMNFOBXYYBO-UHFFFAOYSA-N 4-[2-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]ethyl]morpholine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CCN1CCOCC1)C=1C=C(C=2N(C=1)N=CN=2)OC BPSIMNFOBXYYBO-UHFFFAOYSA-N 0.000 claims 2
- SFWLZPPPTRPMNY-UHFFFAOYSA-N 4-[3-propan-2-yl-5-(4-pyridin-4-yloxycyclohexyl)-1H-indol-2-yl]-1H-pyrazolo[3,4-b]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)OC1=CC=NC=C1)C1=C2C(=NC=C1)NN=C2 SFWLZPPPTRPMNY-UHFFFAOYSA-N 0.000 claims 2
- YMVZQNLNFNTFRA-UHFFFAOYSA-N 4-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]morpholine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)N1CCOCC1)C1=CN2N=CN=C2C(C)=C1C YMVZQNLNFNTFRA-UHFFFAOYSA-N 0.000 claims 2
- TTWKBAJROXFJBP-UHFFFAOYSA-N 4-[4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]-2,6-dimethylmorpholine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)N1CC(C)OC(C)C1 TTWKBAJROXFJBP-UHFFFAOYSA-N 0.000 claims 2
- LAEIJNFHMHEJSR-UHFFFAOYSA-N 4-[4-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]morpholine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)N1CCOCC1)C=1C=C(C=2N(C=1)N=CN=2)C LAEIJNFHMHEJSR-UHFFFAOYSA-N 0.000 claims 2
- CWLKUMPMVPDZTE-UHFFFAOYSA-N 4-[5-(1-piperidin-4-ylethyl)-3-propan-2-yl-1H-indol-2-yl]-1H-pyrazolo[3,4-b]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C(C)C1CCNCC1)C1=C2C(=NC=C1)NN=C2 CWLKUMPMVPDZTE-UHFFFAOYSA-N 0.000 claims 2
- RMZJXKGMOLQTHX-UHFFFAOYSA-N 4-[5-(2-piperidin-4-ylethyl)-3-propan-2-yl-1H-indol-2-yl]-1H-pyrazolo[3,4-b]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CCC1CCNCC1)C1=C2C(=NC=C1)NN=C2 RMZJXKGMOLQTHX-UHFFFAOYSA-N 0.000 claims 2
- PWIOUQALWAWEIL-UHFFFAOYSA-N 4-[5-(4-piperidin-4-yloxycyclohexyl)-3-propan-2-yl-1H-indol-2-yl]-1H-pyrazolo[3,4-b]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)OC1CCNCC1)C1=C2C(=NC=C1)NN=C2 PWIOUQALWAWEIL-UHFFFAOYSA-N 0.000 claims 2
- HOVIACXZDVHHMR-UHFFFAOYSA-N 4-[5-(azepan-4-yl)-3-propan-2-yl-1H-indol-2-yl]-1H-pyrazolo[3,4-b]pyridine Chemical compound N1CCC(CCC1)C=1C=C2C(=C(NC2=CC=1)C1=C2C(=NC=C1)NN=C2)C(C)C HOVIACXZDVHHMR-UHFFFAOYSA-N 0.000 claims 2
- IBTFDGFDHMDFRO-UHFFFAOYSA-N 4-[5-(piperidin-1-ylmethyl)-3-propan-2-yl-1H-indol-2-yl]-1H-pyrazolo[3,4-b]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CN1CCCCC1)C1=C2C(=NC=C1)NN=C2 IBTFDGFDHMDFRO-UHFFFAOYSA-N 0.000 claims 2
- LIKAZLPRJOLYRJ-UHFFFAOYSA-N 4-[5-(piperidin-4-ylmethyl)-3-propan-2-yl-1H-indol-2-yl]-1H-pyrazolo[3,4-b]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CC1CCNCC1)C1=C2C(=NC=C1)NN=C2 LIKAZLPRJOLYRJ-UHFFFAOYSA-N 0.000 claims 2
- HWHYRVJPBKIIGZ-UHFFFAOYSA-N 4-[5-[(4-methylpiperazin-1-yl)methyl]-3-propan-2-yl-1H-indol-2-yl]-1H-pyrazolo[3,4-b]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CN1CCN(CC1)C)C1=C2C(=NC=C1)NN=C2 HWHYRVJPBKIIGZ-UHFFFAOYSA-N 0.000 claims 2
- FMACPBCZPANKIB-ONEGZZNKSA-N 4-[5-[(E)-2-piperidin-4-ylethenyl]-3-propan-2-yl-1H-indol-2-yl]-1H-pyrazolo[3,4-b]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)\C=C\C1CCNCC1)C1=C2C(=NC=C1)NN=C2 FMACPBCZPANKIB-ONEGZZNKSA-N 0.000 claims 2
- DGKAGVRKCVOGBW-UHFFFAOYSA-N 5,5-dimethyl-2-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]morpholine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CNC(C)(C)CO1)C1=CN2N=CN=C2C(C)=C1 DGKAGVRKCVOGBW-UHFFFAOYSA-N 0.000 claims 2
- ANSKPYRXURQDQI-UHFFFAOYSA-N 5-(1-azabicyclo[2.2.2]octan-3-yl)-2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indole Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN2CCC1CC2)C ANSKPYRXURQDQI-UHFFFAOYSA-N 0.000 claims 2
- NBVPFSDORRTCSK-UHFFFAOYSA-N 5-(2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-ylmethyl)-2-(3,4-dimethoxyphenyl)-3-ethyl-1H-indole Chemical compound COC=1C=C(C=CC=1OC)C=1NC2=CC=C(C=C2C=1CC)CN1CC2CNCC2C1 NBVPFSDORRTCSK-UHFFFAOYSA-N 0.000 claims 2
- ZXJWXWVCAMVTQB-UHFFFAOYSA-N 5-(5-cyclohexyl-3-propan-2-yl-1H-indol-2-yl)-1,3-dimethylpyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCCCC1)C1=CN(C)C(=O)C(C)=C1 ZXJWXWVCAMVTQB-UHFFFAOYSA-N 0.000 claims 2
- RSKUHVQQCIUZIL-UHFFFAOYSA-N 5-(azetidin-3-yl)-2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indole Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CNC1)C1=CC(C)=NC(C)=C1 RSKUHVQQCIUZIL-UHFFFAOYSA-N 0.000 claims 2
- JCWSUPGAFPKNRI-UHFFFAOYSA-N 5-[5-(3-aminocyclobutyl)-3-propan-2-yl-1H-indol-2-yl]-1,3,4-trimethylpyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CC(N)C1)C1=CN(C)C(=O)C(C)=C1C JCWSUPGAFPKNRI-UHFFFAOYSA-N 0.000 claims 2
- PQYPJWXEFIQVEP-UHFFFAOYSA-N 5-[5-(azetidin-3-yl)-3-propan-2-yl-1H-indol-2-yl]-1,3,4-trimethylpyridin-2-one Chemical compound N1CC(C1)C=1C=C2C(=C(NC2=CC=1)C=1C(=C(C(N(C=1)C)=O)C)C)C(C)C PQYPJWXEFIQVEP-UHFFFAOYSA-N 0.000 claims 2
- IBWZUUUPFSDXKE-UHFFFAOYSA-N 5-[5-(azetidin-3-ylmethyl)-3-propan-2-yl-1H-indol-2-yl]-1,3,4-trimethylpyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(CC3CNC3)C=C12)C1=CN(C)C(=O)C(C)=C1C IBWZUUUPFSDXKE-UHFFFAOYSA-N 0.000 claims 2
- RSXMXMFCDLGBCJ-UHFFFAOYSA-N 5-[5-[2-(3-fluoropiperidin-1-yl)ethyl]-3-propan-2-yl-1H-indol-2-yl]-1,3-dimethylpyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(CCN3CCCC(F)C3)C=C12)C1=CN(C)C(=O)C(C)=C1 RSXMXMFCDLGBCJ-UHFFFAOYSA-N 0.000 claims 2
- RSIOCNAXSDNODZ-UHFFFAOYSA-N 5-[5-[2-(4-fluoropiperidin-1-yl)ethyl]-3-propan-2-yl-1H-indol-2-yl]-1,3-dimethylpyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(CCN3CCC(F)CC3)C=C12)C1=CN(C)C(=O)C(C)=C1 RSIOCNAXSDNODZ-UHFFFAOYSA-N 0.000 claims 2
- WSSXFHSXPMGWHK-LJQANCHMSA-N 5-[5-[2-[(3R)-3-fluoropyrrolidin-1-yl]ethyl]-3-propan-2-yl-1H-indol-2-yl]-1,3-dimethylpyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(CCN3CC[C@@H](F)C3)C=C12)C1=CN(C)C(=O)C(C)=C1 WSSXFHSXPMGWHK-LJQANCHMSA-N 0.000 claims 2
- WSSXFHSXPMGWHK-IBGZPJMESA-N 5-[5-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethyl]-3-propan-2-yl-1H-indol-2-yl]-1,3-dimethylpyridin-2-one Chemical compound F[C@@H]1CN(CC1)CCC=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)C)=O)C)C(C)C WSSXFHSXPMGWHK-IBGZPJMESA-N 0.000 claims 2
- DXWOCIUJWHLJQS-UHFFFAOYSA-N 5-[5-[4-(dimethylamino)cyclohexyl]-3-propan-2-yl-1H-indol-2-yl]-1,3,4-trimethylpyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)N(C)C)C1=CN(C)C(=O)C(C)=C1C DXWOCIUJWHLJQS-UHFFFAOYSA-N 0.000 claims 2
- OBEZRBVTUUJMRA-UHFFFAOYSA-N 5-cyclohexyl-2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indole Chemical compound C1(CCCCC1)C=1C=C2C(=C(NC2=CC=1)C1=CC(=NC(=C1)C)C)C(C)C OBEZRBVTUUJMRA-UHFFFAOYSA-N 0.000 claims 2
- YJHCVPGBDBXGBB-UHFFFAOYSA-N 5-methyl-6-(5-piperidin-3-yl-3-propan-2-yl-1H-indol-2-yl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCCNC1)C1=C(C)N2N=CN=C2C=C1 YJHCVPGBDBXGBB-UHFFFAOYSA-N 0.000 claims 2
- KAGHIIOPKAISMU-UHFFFAOYSA-N 6-[5-(1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-5-yl)-3-propan-2-yl-1H-indol-2-yl]-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CC2CNCC2C1)C1=CN2N=CN=C2C(C)=C1C KAGHIIOPKAISMU-UHFFFAOYSA-N 0.000 claims 2
- SVXWCDAAJIYENY-UHFFFAOYSA-N 6-[5-(1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-5-yl)-3-propan-2-yl-1H-indol-2-yl]-7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CC2CNCC2C1)C1=CN2C=NN=C2C(C)=C1C SVXWCDAAJIYENY-UHFFFAOYSA-N 0.000 claims 2
- BGZOKTGEBPJSRN-UHFFFAOYSA-N 6-[5-(1-azabicyclo[2.2.2]octan-3-yl)-3-propan-2-yl-1H-indol-2-yl]-8-methyl-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN2CCC1CC2)C1=CN2N=CN=C2C(C)=C1 BGZOKTGEBPJSRN-UHFFFAOYSA-N 0.000 claims 2
- ANCAXXFEXAQKFO-UHFFFAOYSA-N 6-[5-(azetidin-3-yl)-3-propan-2-yl-1H-indol-2-yl]-7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridine Chemical compound N1CC(C1)C=1C=C2C(=C(NC2=CC=1)C=1C(=C(C=2N(C=1)C=NN=2)C)C)C(C)C ANCAXXFEXAQKFO-UHFFFAOYSA-N 0.000 claims 2
- RYAJEHZWCYBXBY-UHFFFAOYSA-N 6-[5-(azetidin-3-yl)-3-propan-2-yl-1H-indol-2-yl]-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine Chemical compound N1CC(C1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C=2N(C=1)N=CN=2)OC)C(C)C RYAJEHZWCYBXBY-UHFFFAOYSA-N 0.000 claims 2
- QCQIHBWIQLVLJN-UHFFFAOYSA-N 6-[5-(azetidin-3-yl)-3-propan-2-yl-1H-indol-2-yl]-8-methyl-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CNC1)C1=CN2N=CN=C2C(C)=C1 QCQIHBWIQLVLJN-UHFFFAOYSA-N 0.000 claims 2
- AGKHSGMNWYDDQR-UHFFFAOYSA-N 6-[5-(azetidin-3-ylmethyl)-3-propan-2-yl-1H-indol-2-yl]-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine Chemical compound N1CC(C1)CC=1C=C2C(=C(NC2=CC=1)C=1C=C(C=2N(C=1)N=CN=2)OC)C(C)C AGKHSGMNWYDDQR-UHFFFAOYSA-N 0.000 claims 2
- UPNWIXSJWLJWAR-UHFFFAOYSA-N 6-[5-[1-(2,2-dimethyloxan-4-yl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-8-methyl-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)C1CCOC(C)(C)C1)C1=CN2N=CN=C2C(C)=C1 UPNWIXSJWLJWAR-UHFFFAOYSA-N 0.000 claims 2
- KOFBUIBBMPIXPE-UHFFFAOYSA-N 6-[5-[1-(2-methoxyethyl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridine Chemical compound COCCN1CC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2C=NN=C2C(C)=C1C KOFBUIBBMPIXPE-UHFFFAOYSA-N 0.000 claims 2
- GCBUDTVJQWRUPH-UHFFFAOYSA-N 6-[5-[2-(azetidin-3-yl)ethyl]-3-propan-2-yl-1H-indol-2-yl]-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine Chemical compound N1CC(C1)CCC=1C=C2C(=C(NC2=CC=1)C=1C=C(C=2N(C=1)N=CN=2)OC)C(C)C GCBUDTVJQWRUPH-UHFFFAOYSA-N 0.000 claims 2
- MDNRXDVMSIQSPD-UHFFFAOYSA-N 6-[5-[4-(3,3-difluoroazetidin-1-yl)cyclohexyl]-3-propan-2-yl-1H-indol-2-yl]-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1(CN(C1)C1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C(=C(C=2N(C=1)N=CN=2)C)C)C(C)C)F MDNRXDVMSIQSPD-UHFFFAOYSA-N 0.000 claims 2
- DKAOGLNGQHRWQE-UHFFFAOYSA-N 6-[5-[4-(3,3-difluoroazetidin-1-yl)cyclohexyl]-3-propan-2-yl-1H-indol-2-yl]-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1(CN(C1)C1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C=2N(C=1)N=CN=2)OC)C(C)C)F DKAOGLNGQHRWQE-UHFFFAOYSA-N 0.000 claims 2
- MXMYYQVBJDAYLO-UHFFFAOYSA-N 6-[5-[4-(3,3-difluoropiperidin-1-yl)cyclohexyl]-3-propan-2-yl-1H-indol-2-yl]-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)N1CCCC(F)(F)C1 MXMYYQVBJDAYLO-UHFFFAOYSA-N 0.000 claims 2
- SENNUCMCEMQQQK-UHFFFAOYSA-N 6-[5-[4-(azetidin-1-yl)cyclohexyl]-3-propan-2-yl-1H-indol-2-yl]-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine Chemical compound N1(CCC1)C1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C=2N(C=1)N=CN=2)OC)C(C)C SENNUCMCEMQQQK-UHFFFAOYSA-N 0.000 claims 2
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 claims 2
- QMYQVLQALQONMY-UHFFFAOYSA-N 7,8-dimethyl-6-(5-piperidin-3-yl-3-propan-2-yl-1H-indol-2-yl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CNCCC1)C=1C(=C(C=2N(C=1)N=CN=2)C)C QMYQVLQALQONMY-UHFFFAOYSA-N 0.000 claims 2
- PSIMWZHQEVCNLM-UHFFFAOYSA-N 7,8-dimethyl-6-[3-propan-2-yl-5-(1-propan-2-ylazetidin-3-yl)-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC(C)N1CC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1C PSIMWZHQEVCNLM-UHFFFAOYSA-N 0.000 claims 2
- KBUOAUXJZYFMGI-UHFFFAOYSA-N 7,8-dimethyl-6-[3-propan-2-yl-5-(1-propan-2-ylazetidin-3-yl)-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)N1CC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2C=NN=C2C(C)=C1C KBUOAUXJZYFMGI-UHFFFAOYSA-N 0.000 claims 2
- UJYUURHFJGMVRS-UHFFFAOYSA-N 7,8-dimethyl-6-[3-propan-2-yl-5-(1-propylazetidin-3-yl)-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)CCC)C=1C(=C(C=2N(C=1)C=NN=2)C)C UJYUURHFJGMVRS-UHFFFAOYSA-N 0.000 claims 2
- GQSGCGWXRRLELF-UHFFFAOYSA-N 7,8-dimethyl-6-[3-propan-2-yl-5-(2-propan-2-yl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl)-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CC2C(CN(C2)C(C)C)C1)C=1C(=C(C=2N(C=1)C=NN=2)C)C GQSGCGWXRRLELF-UHFFFAOYSA-N 0.000 claims 2
- CTKHYSJEADBPLC-UHFFFAOYSA-N 7,8-dimethyl-6-[3-propan-2-yl-5-[(1-propan-2-ylazetidin-3-yl)methyl]-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CC1CN(C1)C(C)C)C=1C(=C(C=2N(C=1)N=CN=2)C)C CTKHYSJEADBPLC-UHFFFAOYSA-N 0.000 claims 2
- FCVDSQFKSQSPHR-UHFFFAOYSA-N 7,8-dimethyl-6-[3-propan-2-yl-5-[1-(2H-triazol-4-ylmethyl)azetidin-3-yl]-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound N1N=NC(=C1)CN1CC(C1)C=1C=C2C(=C(NC2=CC=1)C=1C(=C(C=2N(C=1)N=CN=2)C)C)C(C)C FCVDSQFKSQSPHR-UHFFFAOYSA-N 0.000 claims 2
- LGXUEFRNHSCWLK-UHFFFAOYSA-N 7,8-dimethyl-6-[3-propan-2-yl-5-[1-(4,4,4-trifluorobutyl)azetidin-3-yl]-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)CCCC(F)(F)F)C=1C(=C(C=2N(C=1)C=NN=2)C)C LGXUEFRNHSCWLK-UHFFFAOYSA-N 0.000 claims 2
- MAQCKXNGRAJZLR-UHFFFAOYSA-N 7,8-dimethyl-6-[5-(1-methylazetidin-3-yl)-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(C)C1)C1=CN2N=CN=C2C(C)=C1C MAQCKXNGRAJZLR-UHFFFAOYSA-N 0.000 claims 2
- QNFJWTGMDJVVPL-UHFFFAOYSA-N 7,8-dimethyl-6-[5-(1-methylazetidin-3-yl)-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(C)C1)C1=CN2C=NN=C2C(C)=C1C QNFJWTGMDJVVPL-UHFFFAOYSA-N 0.000 claims 2
- CQCCUQFXCTZRSW-UHFFFAOYSA-N 7,8-dimethyl-6-[5-(2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl)-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CC2C(CN(C2)C)C1)C=1C(=C(C=2N(C=1)C=NN=2)C)C CQCCUQFXCTZRSW-UHFFFAOYSA-N 0.000 claims 2
- MERSXRYCXVVGOD-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[1-(2-methylpropyl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)CN1CC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2C=NN=C2C(C)=C1C MERSXRYCXVVGOD-UHFFFAOYSA-N 0.000 claims 2
- JONZMFFMJKGTEI-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[1-(2-methylsulfonylethyl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CCS(C)(=O)=O)C1)C1=CN2N=CN=C2C(C)=C1C JONZMFFMJKGTEI-UHFFFAOYSA-N 0.000 claims 2
- LWGMLTQOQUWZJF-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[1-(2-methylsulfonylethyl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)CCS(=O)(=O)C)C=1C(=C(C=2N(C=1)C=NN=2)C)C LWGMLTQOQUWZJF-UHFFFAOYSA-N 0.000 claims 2
- KTIQHKDWCYGKDB-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[1-(oxan-4-yl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)C1CCOCC1)C=1C(=C(C=2N(C=1)C=NN=2)C)C KTIQHKDWCYGKDB-UHFFFAOYSA-N 0.000 claims 2
- BNNMFHYMIIQZJP-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[1-(oxetan-3-yl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)C1COC1)C1=CN2N=CN=C2C(C)=C1C BNNMFHYMIIQZJP-UHFFFAOYSA-N 0.000 claims 2
- WMWVFCZAPPRSFT-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[1-(oxetan-3-yl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)C1COC1)C1=CN2C=NN=C2C(C)=C1C WMWVFCZAPPRSFT-UHFFFAOYSA-N 0.000 claims 2
- CXMUNGKAHJBSBE-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[1-(oxolan-3-yl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)C1CCOC1)C1=CN2C=NN=C2C(C)=C1C CXMUNGKAHJBSBE-UHFFFAOYSA-N 0.000 claims 2
- WLUJELYHEAVFOR-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[1-[(1-methyl-1,2,4-triazol-3-yl)methyl]azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC2=NN(C)C=N2)C1)C1=CN2C=NN=C2C(C)=C1C WLUJELYHEAVFOR-UHFFFAOYSA-N 0.000 claims 2
- NVTMVILBKGKGTG-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[1-[(3-methyloxetan-3-yl)methyl]azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC2(C)COC2)C1)C1=CN2C=NN=C2C(C)=C1C NVTMVILBKGKGTG-UHFFFAOYSA-N 0.000 claims 2
- AECRNWXEUVCFON-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[2-(2-methylsulfonylethyl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CC2C(CN(C2)CCS(=O)(=O)C)C1)C=1C(=C(C=2N(C=1)N=CN=2)C)C AECRNWXEUVCFON-UHFFFAOYSA-N 0.000 claims 2
- DJIFNZXOYHFJPU-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[2-(oxan-4-yl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CC2CN(CC2C1)C1CCOCC1)C1=CN2C=NN=C2C(C)=C1C DJIFNZXOYHFJPU-UHFFFAOYSA-N 0.000 claims 2
- VPLLRPRGZYLCMY-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[2-(oxetan-3-yl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CC2CN(CC2C1)C1COC1)C1=CN2C=NN=C2C(C)=C1C VPLLRPRGZYLCMY-UHFFFAOYSA-N 0.000 claims 2
- HXGGEOAXAVIWDL-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[2-(oxolan-3-yl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CC2CN(CC2C1)C1CCOC1)C1=CN2C=NN=C2C(C)=C1C HXGGEOAXAVIWDL-UHFFFAOYSA-N 0.000 claims 2
- LNOWTPNBQRAFAI-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[2-[(3-methyloxetan-3-yl)methyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CC2C(CN(C2)CC2(COC2)C)C1)C=1C(=C(C=2N(C=1)C=NN=2)C)C LNOWTPNBQRAFAI-UHFFFAOYSA-N 0.000 claims 2
- YIHDIJVDDMIDFF-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[[1-(2-methylsulfonylethyl)azetidin-3-yl]methyl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(CC3CN(CCS(C)(=O)=O)C3)C=C12)C1=CN2N=CN=C2C(C)=C1C YIHDIJVDDMIDFF-UHFFFAOYSA-N 0.000 claims 2
- DARWERXAGVJETB-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[[1-(2-methylsulfonylethyl)pyrrolidin-2-yl]methyl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CC1N(CCC1)CCS(=O)(=O)C)C=1C(=C(C=2N(C=1)C=NN=2)C)C DARWERXAGVJETB-UHFFFAOYSA-N 0.000 claims 2
- UGAIORRGKVGSEL-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[[1-(oxan-4-yl)pyrrolidin-2-yl]methyl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(CC3CCCN3C3CCOCC3)C=C12)C1=CN2C=NN=C2C(C)=C1C UGAIORRGKVGSEL-UHFFFAOYSA-N 0.000 claims 2
- GSTJJPFMKLYLEE-UHFFFAOYSA-N 7,8-dimethyl-6-[5-[[1-(oxetan-3-yl)pyrrolidin-2-yl]methyl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CC1N(CCC1)C1COC1)C=1C(=C(C=2N(C=1)C=NN=2)C)C GSTJJPFMKLYLEE-UHFFFAOYSA-N 0.000 claims 2
- CRYQGXSDULVWEI-UHFFFAOYSA-N 8-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]-1,3-diazaspiro[4.5]decane-2,4-dione Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC2(CC1)NC(=O)NC2=O)C1=CC(C)=NC(C)=C1 CRYQGXSDULVWEI-UHFFFAOYSA-N 0.000 claims 2
- KVGGOEAIVCUPIG-UHFFFAOYSA-N 8-methoxy-6-[3-propan-2-yl-5-(1-propan-2-ylazetidin-3-yl)-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CN(C1)C(C)C KVGGOEAIVCUPIG-UHFFFAOYSA-N 0.000 claims 2
- NPFYDNNXAYWGAG-UHFFFAOYSA-N 8-methoxy-6-[3-propan-2-yl-5-(1-propan-2-ylpiperidin-3-yl)-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCCN(C1)C(C)C NPFYDNNXAYWGAG-UHFFFAOYSA-N 0.000 claims 2
- NXXCEDLHCYLAMV-UHFFFAOYSA-N 8-methoxy-6-[3-propan-2-yl-5-(2-pyrrolidin-1-ylethyl)-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(CCN3CCCC3)=CC=C2N1 NXXCEDLHCYLAMV-UHFFFAOYSA-N 0.000 claims 2
- DCFHJRSHUYCVOP-UHFFFAOYSA-N 8-methoxy-6-[3-propan-2-yl-5-[(1-propan-2-ylazetidin-3-yl)methyl]-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CC1CN(C1)C(C)C)C=1C=C(C=2N(C=1)N=CN=2)OC DCFHJRSHUYCVOP-UHFFFAOYSA-N 0.000 claims 2
- RHVPENUJQLCIHY-UHFFFAOYSA-N 8-methoxy-6-[5-(1-methylazetidin-3-yl)-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CN(C)C1 RHVPENUJQLCIHY-UHFFFAOYSA-N 0.000 claims 2
- NAGAEJGKQKPBFW-UHFFFAOYSA-N 8-methoxy-6-[5-(2-piperidin-1-ylethyl)-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(CCN3CCCCC3)=CC=C2N1 NAGAEJGKQKPBFW-UHFFFAOYSA-N 0.000 claims 2
- LWEGWDANUIAREH-UHFFFAOYSA-N 8-methoxy-6-[5-[1-(2-methylsulfonylethyl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)CCS(=O)(=O)C)C=1C=C(C=2N(C=1)N=CN=2)OC LWEGWDANUIAREH-UHFFFAOYSA-N 0.000 claims 2
- NIJZESGLNPNZAN-UHFFFAOYSA-N 8-methoxy-6-[5-[1-(2-methylsulfonylethyl)piperidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCCN(CCS(C)(=O)=O)C1 NIJZESGLNPNZAN-UHFFFAOYSA-N 0.000 claims 2
- SKFRVGNYHDJODH-UHFFFAOYSA-N 8-methoxy-6-[5-[1-(oxetan-3-yl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CN(C1)C1COC1 SKFRVGNYHDJODH-UHFFFAOYSA-N 0.000 claims 2
- WNQZXCCQLJJUFV-UHFFFAOYSA-N 8-methoxy-6-[5-[2-(1-methylazetidin-3-yl)ethyl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(CCC3CN(C)C3)=CC=C2N1 WNQZXCCQLJJUFV-UHFFFAOYSA-N 0.000 claims 2
- DVVVHGNTLJBEIB-UHFFFAOYSA-N 8-methoxy-6-[5-[4-[4-(2-methoxyethyl)piperazin-1-yl]cyclohexyl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COCCN1CCN(CC1)C1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(OC)=C1 DVVVHGNTLJBEIB-UHFFFAOYSA-N 0.000 claims 2
- HFFTYIPQFOPLAR-UHFFFAOYSA-N 8-methoxy-6-[5-[[1-(2-methylsulfonylethyl)azetidin-3-yl]methyl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(CC3CN(CCS(C)(=O)=O)C3)=CC=C2N1 HFFTYIPQFOPLAR-UHFFFAOYSA-N 0.000 claims 2
- KULAXBLYDWZLHN-UHFFFAOYSA-N 8-methyl-6-[3-propan-2-yl-5-(pyrrolidin-2-ylmethyl)-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC(C)C1=C(NC2=CC=C(CC3CCCN3)C=C12)C1=CN2N=CN=C2C(C)=C1 KULAXBLYDWZLHN-UHFFFAOYSA-N 0.000 claims 2
- WXXJJXDRRLKSDU-UHFFFAOYSA-N 8-methyl-6-[5-[1-(2-methylsulfonylethyl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)CCS(=O)(=O)C)C=1C=C(C=2N(C=1)N=CN=2)C WXXJJXDRRLKSDU-UHFFFAOYSA-N 0.000 claims 2
- LZEMNMDHAUHURR-UHFFFAOYSA-N 8-methyl-6-[5-[1-(oxetan-3-yl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)C1COC1)C=1C=C(C=2N(C=1)N=CN=2)C LZEMNMDHAUHURR-UHFFFAOYSA-N 0.000 claims 2
- BSLDEUUPNRMYDN-UHFFFAOYSA-N 8-methyl-6-[5-[[1-(oxan-4-yl)pyrrolidin-2-yl]methyl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CC1N(CCC1)C1CCOCC1)C=1C=C(C=2N(C=1)N=CN=2)C BSLDEUUPNRMYDN-UHFFFAOYSA-N 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- DMDNVLYDSBZOQU-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1OCC(N(C1)CC(C)(O)C)(C)C)C=1C=C(C=2N(C=1)N=CN=2)C Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1OCC(N(C1)CC(C)(O)C)(C)C)C=1C=C(C=2N(C=1)N=CN=2)C DMDNVLYDSBZOQU-UHFFFAOYSA-N 0.000 claims 2
- HBQJBKXXSFSXDM-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1OCCN(C1)C(CNC1(COC1)C)=O)C=1C=C(C=2N(C=1)N=CN=2)OC Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1OCCN(C1)C(CNC1(COC1)C)=O)C=1C=C(C=2N(C=1)N=CN=2)OC HBQJBKXXSFSXDM-UHFFFAOYSA-N 0.000 claims 2
- JHGZMFHMPZCPOX-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)CCN1CCOCC1)C=1C=C(C(N(C=1)C)=O)C Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)CCN1CCOCC1)C=1C=C(C(N(C=1)C)=O)C JHGZMFHMPZCPOX-UHFFFAOYSA-N 0.000 claims 2
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 claims 2
- WYHMTUOVJQZDLG-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)N1CC(CO)(CO)C1)C1=CN2N=CN=C2C(C)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)N1CC(CO)(CO)C1)C1=CN2N=CN=C2C(C)=C1C WYHMTUOVJQZDLG-UHFFFAOYSA-N 0.000 claims 2
- XBXDYVKEHPNBMA-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(=O)N(C)C)C(C)(C)CO1)C1=CN2N=CN=C2C(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(=O)N(C)C)C(C)(C)CO1)C1=CN2N=CN=C2C(C)=C1 XBXDYVKEHPNBMA-UHFFFAOYSA-N 0.000 claims 2
- MPWNXPHVQCTTEX-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(C)(C)O)CCO1)C1=CC(C)=NC(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(C)(C)O)CCO1)C1=CC(C)=NC(C)=C1 MPWNXPHVQCTTEX-UHFFFAOYSA-N 0.000 claims 2
- WHSCWFRQGYESLW-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CCO1)C(=O)CN(C)C)C1=CN2N=CN=C2C(C)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CCO1)C(=O)CN(C)C)C1=CN2N=CN=C2C(C)=C1C WHSCWFRQGYESLW-UHFFFAOYSA-N 0.000 claims 2
- QSELSCCXYIQHPH-UHFFFAOYSA-N CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1OCC(N(C1)CC(=O)N(C)C)(C)C)N=CN=2)C Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1OCC(N(C1)CC(=O)N(C)C)(C)C)N=CN=2)C QSELSCCXYIQHPH-UHFFFAOYSA-N 0.000 claims 2
- DSBMMSNSIWAVBN-UHFFFAOYSA-N CN(CC(=O)N1CC(C1)C=1C=C2C(=C(NC2=CC=1)C=1C(=C(C(N(C=1)C)=O)C)C)C(C)C)C Chemical compound CN(CC(=O)N1CC(C1)C=1C=C2C(=C(NC2=CC=1)C=1C(=C(C(N(C=1)C)=O)C)C)C(C)C)C DSBMMSNSIWAVBN-UHFFFAOYSA-N 0.000 claims 2
- ZFVNTBRYSIMACI-UHFFFAOYSA-N CN(CC(=O)N1CC(C1)CC=1C=C2C(=C(NC2=CC=1)C=1C(=C(C(N(C=1)C)=O)C)C)C(C)C)C Chemical compound CN(CC(=O)N1CC(C1)CC=1C=C2C(=C(NC2=CC=1)C=1C(=C(C(N(C=1)C)=O)C)C)C(C)C)C ZFVNTBRYSIMACI-UHFFFAOYSA-N 0.000 claims 2
- JZGIQNHOVJDXDM-UHFFFAOYSA-N CNC(=O)CN1CC(OCC1(C)C)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1C Chemical compound CNC(=O)CN1CC(OCC1(C)C)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1C JZGIQNHOVJDXDM-UHFFFAOYSA-N 0.000 claims 2
- JZKLZCUVYRRZMR-UHFFFAOYSA-N CNCC(=O)N1CCOC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1 Chemical compound CNCC(=O)N1CCOC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1 JZKLZCUVYRRZMR-UHFFFAOYSA-N 0.000 claims 2
- PAXQBFVSPRHFJD-UHFFFAOYSA-N CNCC(=O)N1CCOC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1C Chemical compound CNCC(=O)N1CCOC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1C PAXQBFVSPRHFJD-UHFFFAOYSA-N 0.000 claims 2
- WDSGXGPCIDPXSS-UHFFFAOYSA-N N,N-dimethyl-2-[2-[[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]methyl]pyrrolidin-1-yl]acetamide Chemical compound CC(C)C1=C(NC2=CC=C(CC3CCCN3CC(=O)N(C)C)C=C12)C1=CN2N=CN=C2C(C)=C1 WDSGXGPCIDPXSS-UHFFFAOYSA-N 0.000 claims 2
- MUAPSYZVMLHDCK-UHFFFAOYSA-N N,N-dimethyl-2-[3-[3-propan-2-yl-2-(1,4,5-trimethyl-6-oxopyridin-3-yl)-1H-indol-5-yl]azetidin-1-yl]acetamide Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(C1)CC(=O)N(C)C)C1=CN(C(C(=C1C)C)=O)C MUAPSYZVMLHDCK-UHFFFAOYSA-N 0.000 claims 2
- VSPZRISUIJJCNA-UHFFFAOYSA-N N,N-dimethyl-2-[methyl-[4-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]amino]acetamide Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)N(C)CC(=O)N(C)C)C1=CN2N=CN=C2C(C)=C1 VSPZRISUIJJCNA-UHFFFAOYSA-N 0.000 claims 2
- WCBOLDXKGHCHAL-UHFFFAOYSA-N N-(2,2-difluoroethyl)-4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)NCC(F)F WCBOLDXKGHCHAL-UHFFFAOYSA-N 0.000 claims 2
- RMONMJQVIKJDNK-UHFFFAOYSA-N N-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclobutyl]oxetan-3-amine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CC(C1)NC1COC1)C1=CN2N=CN=C2C(C)=C1C RMONMJQVIKJDNK-UHFFFAOYSA-N 0.000 claims 2
- JBYMFLNXHARTEP-UHFFFAOYSA-N N-[3-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclobutyl]oxetan-3-amine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CC(C1)NC1COC1 JBYMFLNXHARTEP-UHFFFAOYSA-N 0.000 claims 2
- JJHJWGYRXRLUHT-UHFFFAOYSA-N N-[4-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]oxetan-3-amine Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CCC(CC1)NC1COC1)C JJHJWGYRXRLUHT-UHFFFAOYSA-N 0.000 claims 2
- IXFHLYLKYCVIGJ-UHFFFAOYSA-N N-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]-3-methyloxetan-3-amine Chemical compound CC1=C(C2=NC=NN2C=C1C3=C(C4=C(N3)C=CC(=C4)C5CCC(CC5)NC6(COC6)C)C(C)C)C IXFHLYLKYCVIGJ-UHFFFAOYSA-N 0.000 claims 2
- GIGHRBHIDNJOMT-UHFFFAOYSA-N N-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]oxetan-3-amine Chemical compound CC1=C(C2=NC=NN2C=C1C3=C(C4=C(N3)C=CC(=C4)C5CCC(CC5)NC6COC6)C(C)C)C GIGHRBHIDNJOMT-UHFFFAOYSA-N 0.000 claims 2
- RXPRNGLGXPRLSJ-UHFFFAOYSA-N N-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]oxetan-3-amine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NC1COC1)C1=CN2C=NN=C2C(C)=C1C RXPRNGLGXPRLSJ-UHFFFAOYSA-N 0.000 claims 2
- AWIBFFMIQNJGKF-UHFFFAOYSA-N N-[4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]acetamide Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NC(C)=O)C=1C=C(C=2N(C=1)N=CN=2)OC AWIBFFMIQNJGKF-UHFFFAOYSA-N 0.000 claims 2
- PCQWFRCQNCLTKW-UHFFFAOYSA-N N-[4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]methanesulfonamide Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NS(=O)(=O)C)C=1C=C(C=2N(C=1)N=CN=2)OC PCQWFRCQNCLTKW-UHFFFAOYSA-N 0.000 claims 2
- XQHSHJAACRBZCF-UHFFFAOYSA-N N-[[3-ethyl-2-(2-methylpyridin-4-yl)-1H-indol-5-yl]methyl]-1-methylpiperidine-4-carboxamide Chemical compound C(C)C1=C(NC2=CC=C(C=C12)CNC(=O)C1CCN(CC1)C)C1=CC(=NC=C1)C XQHSHJAACRBZCF-UHFFFAOYSA-N 0.000 claims 2
- SRYSYFRCBDMYCZ-UHFFFAOYSA-N N-[[3-ethyl-2-(2-methylpyridin-4-yl)-1H-indol-5-yl]methyl]-4-methylpiperazine-1-carboxamide Chemical compound C(C)C1=C(NC2=CC=C(C=C12)CNC(=O)N1CCN(CC1)C)C1=CC(=NC=C1)C SRYSYFRCBDMYCZ-UHFFFAOYSA-N 0.000 claims 2
- JSRVJFUWYJHQSD-UHFFFAOYSA-N N-[[3-ethyl-2-(2-methylpyridin-4-yl)-1H-indol-5-yl]methyl]-7-azaspiro[3.5]nonane-2-carboxamide Chemical compound C(C)C1=C(NC2=CC=C(C=C12)CNC(=O)C1CC2(C1)CCNCC2)C1=CC(=NC=C1)C JSRVJFUWYJHQSD-UHFFFAOYSA-N 0.000 claims 2
- OXWNDNNYYYOWBS-UHFFFAOYSA-N N-[[3-ethyl-2-(2-methylpyridin-4-yl)-1H-indol-5-yl]methyl]pyrrolidine-3-carboxamide Chemical compound C(C)C1=C(NC2=CC=C(C=C12)CNC(=O)C1CNCC1)C1=CC(=NC=C1)C OXWNDNNYYYOWBS-UHFFFAOYSA-N 0.000 claims 2
- DFZACIAVORBTPM-UHFFFAOYSA-N N-cyclopropyl-4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methylcyclohexan-1-amine Chemical compound C1(CC1)N(C1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C=2N(C=1)N=CN=2)OC)C(C)C)C DFZACIAVORBTPM-UHFFFAOYSA-N 0.000 claims 2
- RIBSXSIVMFKYLZ-UHFFFAOYSA-N N-cyclopropyl-4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)NC1CC1 RIBSXSIVMFKYLZ-UHFFFAOYSA-N 0.000 claims 2
- DVCXFVLWQWYRKT-UHFFFAOYSA-N N-cyclopropyl-4-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound C1(CC1)NC1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C=2N(C=1)N=CN=2)C)C(C)C DVCXFVLWQWYRKT-UHFFFAOYSA-N 0.000 claims 2
- ITACBXSUSSJVQJ-UHFFFAOYSA-N N-ethyl-4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methylcyclohexan-1-amine Chemical compound CCN(C)C1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(OC)=C1 ITACBXSUSSJVQJ-UHFFFAOYSA-N 0.000 claims 2
- OHNMYUQTAZKOIO-UHFFFAOYSA-N N-ethyl-N-methyl-4-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound CCN(C)C1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1 OHNMYUQTAZKOIO-UHFFFAOYSA-N 0.000 claims 2
- SHZTZCOOAYCZBA-UHFFFAOYSA-N N-methoxy-4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methylcyclohexan-1-amine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)N(OC)C)C=1C=C(C=2N(C=1)N=CN=2)OC SHZTZCOOAYCZBA-UHFFFAOYSA-N 0.000 claims 2
- DKZLQBMOQNFVSX-UHFFFAOYSA-N N-methyl-2-[3-[2-(2-methylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]ethanamine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(CCC1)CCNC)C1=CC(=NC=C1)C DKZLQBMOQNFVSX-UHFFFAOYSA-N 0.000 claims 2
- ZVWWWTVXPTZMKD-UHFFFAOYSA-N N-methyl-2-[[4-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]amino]acetamide Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NCC(=O)NC)C=1C=C(C=2N(C=1)N=CN=2)C ZVWWWTVXPTZMKD-UHFFFAOYSA-N 0.000 claims 2
- RZWBYPDJOBNQCN-UHFFFAOYSA-N [3-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-(3-methyloxetan-3-yl)methanone Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCC1)C(=O)C1(COC1)C)C RZWBYPDJOBNQCN-UHFFFAOYSA-N 0.000 claims 2
- OFOHBBDOSCGXFL-UHFFFAOYSA-N [3-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-(1-methylpiperidin-4-yl)methanone Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(CCC1)C(=O)C1CCN(CC1)C)C=1C=C(C=2N(C=1)N=CN=2)OC OFOHBBDOSCGXFL-UHFFFAOYSA-N 0.000 claims 2
- GWGQAFDDGBFZJQ-UHFFFAOYSA-N [3-ethyl-2-(2-methylpyridin-4-yl)-1H-indol-5-yl]methanamine Chemical compound C(C)C1=C(NC2=CC=C(C=C12)CN)C1=CC(=NC=C1)C GWGQAFDDGBFZJQ-UHFFFAOYSA-N 0.000 claims 2
- YFGFNHOHRYLFMS-UHFFFAOYSA-N azetidin-3-yl-[3-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]methanone Chemical compound N1CC(C1)C(=O)N1CC(CCC1)C=1C=C2C(=C(NC2=CC=1)C1=CC(=NC(=C1)C)C)C(C)C YFGFNHOHRYLFMS-UHFFFAOYSA-N 0.000 claims 2
- 208000037976 chronic inflammation Diseases 0.000 claims 2
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 2
- KZZKOVLJUKWSKX-UHFFFAOYSA-N cyclobutanamine Chemical compound NC1CCC1 KZZKOVLJUKWSKX-UHFFFAOYSA-N 0.000 claims 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims 2
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 2
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- WAMIMFBUKQWNAN-YMBRHYMPSA-N (2R)-1-[3-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-2-(methylamino)propan-1-one Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCC1)C([C@@H](C)NC)=O)C WAMIMFBUKQWNAN-YMBRHYMPSA-N 0.000 claims 1
- HRONVGJIPVILRM-UHFFFAOYSA-N 1,3,4-trimethyl-5-[5-[4-(oxetan-3-ylamino)cyclohexyl]-3-propan-2-yl-1H-indol-2-yl]pyridin-2-one Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NC1COC1)C=1C(=C(C(N(C=1)C)=O)C)C HRONVGJIPVILRM-UHFFFAOYSA-N 0.000 claims 1
- VFQJQCBGXXZCTM-UHFFFAOYSA-N 1-[3-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-2-ethylbutan-1-one Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCC1)C(C(CC)CC)=O)C VFQJQCBGXXZCTM-UHFFFAOYSA-N 0.000 claims 1
- HVNKTMKSIYIGRR-UHFFFAOYSA-N 1-[3-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-2-methoxyethanone Chemical compound COCC(=O)N1CCCC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CC(C)=NC(C)=C1 HVNKTMKSIYIGRR-UHFFFAOYSA-N 0.000 claims 1
- KUUXETVWVOVZLH-UHFFFAOYSA-N 2-(2-methylpyridin-4-yl)-3-propan-2-yl-1H-indole Chemical compound C(C)(C)C1=C(NC2=CC=CC=C12)C1=CC(=NC=C1)C KUUXETVWVOVZLH-UHFFFAOYSA-N 0.000 claims 1
- MKYBVOGMWSDIPH-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-piperidin-3-yl-3-propan-2-yl-1H-indole Chemical compound COC1=C(OC)C=C(C=C1)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCCNC1 MKYBVOGMWSDIPH-UHFFFAOYSA-N 0.000 claims 1
- MSTINECIUDWUAV-UHFFFAOYSA-N 2-(dimethylamino)-1-[2-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]morpholin-4-yl]ethanone Chemical compound CN(CC(=O)N1CC(OCC1)C=1C=C2C(=C(NC2=CC=1)C1=CC(=NC(=C1)C)C)C(C)C)C MSTINECIUDWUAV-UHFFFAOYSA-N 0.000 claims 1
- NETIQPLZIFLUGN-UHFFFAOYSA-N 2-(dimethylamino)-N-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclobutyl]-N-methylacetamide Chemical compound CC(C)C1=C(NC2=C1C=C(C=C2)C1CC(C1)N(C)C(=O)CN(C)C)C1=CN2N=CN=C2C(C)=C1C NETIQPLZIFLUGN-UHFFFAOYSA-N 0.000 claims 1
- OHJQEYRKNCZFPV-UHFFFAOYSA-N 2-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]-4-(2-methoxyethyl)morpholine Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCO1)CCOC)C OHJQEYRKNCZFPV-UHFFFAOYSA-N 0.000 claims 1
- UNUDXGZWQAAPCF-UHFFFAOYSA-N 2-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]-4-(2-methylsulfonylethyl)morpholine Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCO1)CCS(=O)(=O)C)C UNUDXGZWQAAPCF-UHFFFAOYSA-N 0.000 claims 1
- YFHVZRBLNAKVHI-UHFFFAOYSA-N 2-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]-4-propan-2-ylmorpholine Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCO1)C(C)C)C YFHVZRBLNAKVHI-UHFFFAOYSA-N 0.000 claims 1
- QRUJQICFUNAZLI-UHFFFAOYSA-N 2-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]morpholine Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CNCCO1)N=CN=2)C QRUJQICFUNAZLI-UHFFFAOYSA-N 0.000 claims 1
- MDHZBYARXMWYGG-UHFFFAOYSA-N 2-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-4-methylmorpholine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CN(CCO1)C)C=1C=C(C=2N(C=1)N=CN=2)OC MDHZBYARXMWYGG-UHFFFAOYSA-N 0.000 claims 1
- YCDBBJDDBXIUNY-UHFFFAOYSA-N 2-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-4-propan-2-ylmorpholine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CN(CCO1)C(C)C YCDBBJDDBXIUNY-UHFFFAOYSA-N 0.000 claims 1
- LYXKEQPCODEGGY-UHFFFAOYSA-N 2-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-4-propan-2-ylmorpholine Chemical compound C(C)(C)N1CC(OCC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C=2N(C=1)N=CN=2)C)C(C)C LYXKEQPCODEGGY-UHFFFAOYSA-N 0.000 claims 1
- YFCNOJWENWIRKT-UHFFFAOYSA-N 2-[3-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-N,N-dimethylacetamide Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCCN(CC(=O)N(C)C)C1)C1=CC(C)=NC(C)=C1 YFCNOJWENWIRKT-UHFFFAOYSA-N 0.000 claims 1
- UGNCNQLNUYIDEF-UHFFFAOYSA-N 2-[3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]-N,N-dimethylacetamide Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCCN(CC(=O)N(C)C)C1)C1=CN2N=CN=C2C(C)=C1C UGNCNQLNUYIDEF-UHFFFAOYSA-N 0.000 claims 1
- PQGRLPZFTVJMPZ-UHFFFAOYSA-N 3-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methyl-N-(2-methylsulfonylethyl)cyclobutan-1-amine Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CC(C1)N(CCS(=O)(=O)C)C)N=CN=2)C PQGRLPZFTVJMPZ-UHFFFAOYSA-N 0.000 claims 1
- KJZBBZBUNRHLHR-UHFFFAOYSA-N 3-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methyl-N-(2-methylsulfonylethyl)cyclobutan-1-amine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CC(C1)N(C)CCS(C)(=O)=O KJZBBZBUNRHLHR-UHFFFAOYSA-N 0.000 claims 1
- KRUGTRHYCLITLI-UHFFFAOYSA-N 3-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclobutan-1-amine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CC(C1)N)C=1C=C(C=2N(C=1)N=CN=2)OC KRUGTRHYCLITLI-UHFFFAOYSA-N 0.000 claims 1
- HZHQFGBULMGMSS-UHFFFAOYSA-N 4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N,N-dimethylcyclohexan-1-amine Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CCC(CC1)N(C)C)N=CN=2)C HZHQFGBULMGMSS-UHFFFAOYSA-N 0.000 claims 1
- SCNDFNQMLCIEQP-UHFFFAOYSA-N 4-[2-(7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N,N-dimethylcyclohexan-1-amine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)N(C)C)C1=CN2C=NN=C2C(C)=C1C SCNDFNQMLCIEQP-UHFFFAOYSA-N 0.000 claims 1
- UEFKDQGCYSZPFN-UHFFFAOYSA-N 4-[2-(7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methylcyclohexan-1-amine Chemical compound CC1=C(C=2N(C=C1C=1NC3=CC=C(C=C3C=1C(C)C)C1CCC(CC1)NC)C=NN=2)C UEFKDQGCYSZPFN-UHFFFAOYSA-N 0.000 claims 1
- FNRVTSPENOSBFI-UHFFFAOYSA-N 4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-(2,2,2-trifluoroethyl)cyclohexan-1-amine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)NCC(F)(F)F FNRVTSPENOSBFI-UHFFFAOYSA-N 0.000 claims 1
- UQWDSPJYEYSSCR-UHFFFAOYSA-N 4-[3-[2-(2,6-dimethylpyridin-4-yl)-3-propan-2-yl-1H-indol-5-yl]azetidin-1-yl]thiane 1,1-dioxide Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(C1)C1CCS(CC1)(=O)=O)C UQWDSPJYEYSSCR-UHFFFAOYSA-N 0.000 claims 1
- ZATIOXQDTGJNGL-UHFFFAOYSA-N 4-[4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]morpholine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)N1CCOCC1)C=1C=C(C=2N(C=1)N=CN=2)OC ZATIOXQDTGJNGL-UHFFFAOYSA-N 0.000 claims 1
- MWYMRJJYTOSUJX-UHFFFAOYSA-N 4-[4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]piperazin-2-one Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)N1CCNC(=O)C1 MWYMRJJYTOSUJX-UHFFFAOYSA-N 0.000 claims 1
- GWMOYVJKPKAIQH-UHFFFAOYSA-N 4-methyl-2-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]morpholine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(C)CCO1)C1=CN2N=CN=C2C(C)=C1 GWMOYVJKPKAIQH-UHFFFAOYSA-N 0.000 claims 1
- UCUMELNLNOMMSP-UHFFFAOYSA-N 5,5-dimethyl-4-(2-methylsulfonylethyl)-2-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]morpholine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CCS(C)(=O)=O)C(C)(C)CO1)C1=CN2N=CN=C2C(C)=C1 UCUMELNLNOMMSP-UHFFFAOYSA-N 0.000 claims 1
- IUJVIBSJKDJMEI-UHFFFAOYSA-N 5-[5-[1-(2-methoxyethyl)azetidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-1,3,4-trimethylpyridin-2-one Chemical compound COCCN1CC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN(C)C(=O)C(C)=C1C IUJVIBSJKDJMEI-UHFFFAOYSA-N 0.000 claims 1
- JUUFYCBATDXZKT-UHFFFAOYSA-N 5-[5-[2-(3,3-difluoropiperidin-1-yl)ethyl]-3-propan-2-yl-1H-indol-2-yl]-1,3-dimethylpyridin-2-one Chemical compound CC(C)C1=C(NC2=CC=C(CCN3CCCC(F)(F)C3)C=C12)C1=CN(C)C(=O)C(C)=C1 JUUFYCBATDXZKT-UHFFFAOYSA-N 0.000 claims 1
- DHVAQOUMEPMNLZ-UHFFFAOYSA-N 5-[5-[4-(3,3-difluoropiperidin-1-yl)cyclohexyl]-3-propan-2-yl-1H-indol-2-yl]-1,3-dimethylpyridin-2-one Chemical compound FC1(CN(CCC1)C1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)C)=O)C)C(C)C)F DHVAQOUMEPMNLZ-UHFFFAOYSA-N 0.000 claims 1
- CYVUTDJAPMGNEE-UHFFFAOYSA-N 5-[5-[4-(4,4-difluoropiperidin-1-yl)cyclohexyl]-3-propan-2-yl-1H-indol-2-yl]-1,3-dimethylpyridin-2-one Chemical compound FC1(CCN(CC1)C1CCC(CC1)C=1C=C2C(=C(NC2=CC=1)C=1C=C(C(N(C=1)C)=O)C)C(C)C)F CYVUTDJAPMGNEE-UHFFFAOYSA-N 0.000 claims 1
- JHJGZZMFOIXHOT-UHFFFAOYSA-N 6-[5-[4-(3-fluoroazetidin-1-yl)cyclohexyl]-3-propan-2-yl-1H-indol-2-yl]-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)N1CC(F)C1 JHJGZZMFOIXHOT-UHFFFAOYSA-N 0.000 claims 1
- MDKDJCPKBRNUCD-UHFFFAOYSA-N 8-methoxy-6-(3-propan-2-yl-1H-indol-2-yl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C1=C(NC2=CC=CC=C12)C=1C=C(C=2N(C=1)N=CN=2)OC MDKDJCPKBRNUCD-UHFFFAOYSA-N 0.000 claims 1
- UJKVFOUJQJKPSR-UHFFFAOYSA-N 8-methoxy-6-[5-(1-methylpiperidin-3-yl)-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCCN(C)C1 UJKVFOUJQJKPSR-UHFFFAOYSA-N 0.000 claims 1
- NWRHSIYJBPRNGK-UHFFFAOYSA-N 8-methoxy-6-[5-[1-(oxetan-3-yl)piperidin-3-yl]-3-propan-2-yl-1H-indol-2-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCCN(C1)C1COC1 NWRHSIYJBPRNGK-UHFFFAOYSA-N 0.000 claims 1
- JPYAPLMBMJENER-UHFFFAOYSA-N C(C)(C)C1=C(NC2=CC=C(C=C12)C1OCCN(C1)CC(=O)NC)C=1C=C(C=2N(C=1)N=CN=2)OC Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1OCCN(C1)CC(=O)NC)C=1C=C(C=2N(C=1)N=CN=2)OC JPYAPLMBMJENER-UHFFFAOYSA-N 0.000 claims 1
- DQSJIIDQWSUHQW-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(=O)N(C)C)CCO1)C1=CC(C)=NC(C)=C1 Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(=O)N(C)C)CCO1)C1=CC(C)=NC(C)=C1 DQSJIIDQWSUHQW-UHFFFAOYSA-N 0.000 claims 1
- LXAPQEJQWWOALE-UHFFFAOYSA-N CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(=O)N(C)C)CCO1)C1=CN2N=CN=C2C(C)=C1C Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CN(CC(=O)N(C)C)CCO1)C1=CN2N=CN=C2C(C)=C1C LXAPQEJQWWOALE-UHFFFAOYSA-N 0.000 claims 1
- BKFZNWGHDJEGHC-UHFFFAOYSA-N CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCC1)C(=O)C1(CC1)C)C Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1CN(CCC1)C(=O)C1(CC1)C)C BKFZNWGHDJEGHC-UHFFFAOYSA-N 0.000 claims 1
- HBILEPSVTGEPAC-UHFFFAOYSA-N CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1OCCN(C1)CC(=O)NC)C Chemical compound CC1=NC(=CC(=C1)C=1NC2=CC=C(C=C2C=1C(C)C)C1OCCN(C1)CC(=O)NC)C HBILEPSVTGEPAC-UHFFFAOYSA-N 0.000 claims 1
- MWCVTYIVSBAJTB-UHFFFAOYSA-N CNC(=O)CN1CCOC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1 Chemical compound CNC(=O)CN1CCOC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1 MWCVTYIVSBAJTB-UHFFFAOYSA-N 0.000 claims 1
- BSIHZGUFRRKSOM-UHFFFAOYSA-N CNC(=O)CN1CCOC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1C Chemical compound CNC(=O)CN1CCOC(C1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1C BSIHZGUFRRKSOM-UHFFFAOYSA-N 0.000 claims 1
- RQHUUACNRZKHHA-UHFFFAOYSA-N COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CN(CC(=O)N(C)C)CCO1 Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CN(CC(=O)N(C)C)CCO1 RQHUUACNRZKHHA-UHFFFAOYSA-N 0.000 claims 1
- VXKIHAAHZKZPAL-UHFFFAOYSA-N N,N-dimethyl-2-[[4-[3-propan-2-yl-2-(1,4,5-trimethyl-6-oxopyridin-3-yl)-1H-indol-5-yl]cyclohexyl]amino]acetamide Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NCC(=O)N(C)C)C1=CN(C)C(=O)C(C)=C1C VXKIHAAHZKZPAL-UHFFFAOYSA-N 0.000 claims 1
- PMYZFDKPIUHKDR-UHFFFAOYSA-N N-(2,2-difluoroethyl)-4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]-N-methylcyclohexan-1-amine Chemical compound COC1=CC(=CN2N=CN=C12)C1=C(C(C)C)C2=CC(=CC=C2N1)C1CCC(CC1)N(C)CC(F)F PMYZFDKPIUHKDR-UHFFFAOYSA-N 0.000 claims 1
- LDCBNHJEBAMNGK-UHFFFAOYSA-N N-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]-N-methyloxetan-3-amine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)N(C)C1COC1)C1=CN2C=NN=C2C(C)=C1C LDCBNHJEBAMNGK-UHFFFAOYSA-N 0.000 claims 1
- BNEVBCJGQGKVPR-UHFFFAOYSA-N N-[4-[2-(8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]oxetan-3-amine Chemical compound C(C)(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NC1COC1)C=1C=C(C=2N(C=1)N=CN=2)OC BNEVBCJGQGKVPR-UHFFFAOYSA-N 0.000 claims 1
- ABTMGUCUMKDJDV-UHFFFAOYSA-N N-[4-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexyl]oxetan-3-amine Chemical compound CC(C)C1=C(NC2=CC=C(C=C12)C1CCC(CC1)NC1COC1)C1=CN2N=CN=C2C(C)=C1 ABTMGUCUMKDJDV-UHFFFAOYSA-N 0.000 claims 1
- VARXHZBHGXKZLH-UHFFFAOYSA-N N-cyclopropyl-4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound CC1=C(C2=NC=NN2C=C1C3=C(C4=C(N3)C=CC(=C4)C5CCC(CC5)NC6CC6)C(C)C)C VARXHZBHGXKZLH-UHFFFAOYSA-N 0.000 claims 1
- YJJZONIJNUTYJC-UHFFFAOYSA-N N-methyl-4-[2-(8-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]cyclohexan-1-amine Chemical compound CNC1CCC(CC1)C1=CC=C2NC(=C(C(C)C)C2=C1)C1=CN2N=CN=C2C(C)=C1 YJJZONIJNUTYJC-UHFFFAOYSA-N 0.000 claims 1
- 208000021386 Sjogren Syndrome Diseases 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 1
- AIMMVWOEOZMVMS-UHFFFAOYSA-N cyclopropanecarboxamide Chemical compound NC(=O)C1CC1 AIMMVWOEOZMVMS-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 1
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 claims 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 1
- VLJNHYLEOZPXFW-UHFFFAOYSA-N pyrrolidine-2-carboxamide Chemical compound NC(=O)C1CCCN1 VLJNHYLEOZPXFW-UHFFFAOYSA-N 0.000 claims 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000005505 thiomorpholino group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762607472P | 2017-12-19 | 2017-12-19 | |
| US62/607,472 | 2017-12-19 | ||
| PCT/US2018/066149 WO2019126113A1 (en) | 2017-12-19 | 2018-12-18 | Substituted indole compounds useful as tlr inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021506889A JP2021506889A (ja) | 2021-02-22 |
| JP2021506889A5 true JP2021506889A5 (enExample) | 2021-12-23 |
| JP7291145B2 JP7291145B2 (ja) | 2023-06-14 |
Family
ID=65003586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020534224A Active JP7291145B2 (ja) | 2017-12-19 | 2018-12-18 | Tlr阻害剤として有効な置換されたインドール化合物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11878975B2 (enExample) |
| EP (1) | EP3728225B1 (enExample) |
| JP (1) | JP7291145B2 (enExample) |
| KR (1) | KR102742178B1 (enExample) |
| CN (1) | CN111491930B (enExample) |
| AU (1) | AU2018390820A1 (enExample) |
| BR (1) | BR112020012084A2 (enExample) |
| CA (1) | CA3085590A1 (enExample) |
| EA (1) | EA202091474A1 (enExample) |
| ES (1) | ES2932361T3 (enExample) |
| IL (1) | IL275356A (enExample) |
| MX (1) | MX2020005462A (enExample) |
| SG (1) | SG11202005696YA (enExample) |
| WO (1) | WO2019126113A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10071079B2 (en) | 2016-06-29 | 2018-09-11 | Bristol-Myers Squibb Company | [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds |
| JP7304352B2 (ja) * | 2017-12-19 | 2023-07-06 | ブリストル-マイヤーズ スクイブ カンパニー | 6-アザインドール化合物 |
| AU2018390610A1 (en) * | 2017-12-20 | 2020-08-06 | Bristol-Myers Squibb Company | Amino indole compounds useful as TLR inhibitors |
| US11420958B2 (en) * | 2017-12-20 | 2022-08-23 | Bristol-Myers Squibb Company | Aryl and heteroaryl substituted indole compounds |
| EP3752505B1 (en) | 2018-02-12 | 2023-01-11 | F. Hoffmann-La Roche AG | Novel sulfone compounds and derivatives for the treatment and prophylaxis of virus infection |
| AU2019280728A1 (en) | 2018-06-05 | 2020-11-12 | F. Hoffmann-La Roche Ag | Tetrahydro-1 H-pyrazino[2,1 -ajisoindolylquinoline compounds for the treatment of autoimmune disease |
| TW202016105A (zh) | 2018-06-12 | 2020-05-01 | 瑞士商赫孚孟拉羅股份公司 | 用於治療自體免疫疾病的新穎雜芳基雜環基化合物 |
| EP3826724B1 (en) | 2018-07-23 | 2022-10-05 | F. Hoffmann-La Roche AG | Novel piperazine compounds for the treatment of autoimmune disease |
| EP3847169A1 (en) | 2018-09-04 | 2021-07-14 | F. Hoffmann-La Roche AG | Benzothiazole compounds for the treatment of autoimmune diseases |
| JP2022502353A (ja) | 2018-09-06 | 2022-01-11 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 自己免疫疾患の処置のための新規の環状アミジン化合物 |
| EP3847173B1 (en) | 2018-09-06 | 2023-04-12 | F. Hoffmann-La Roche AG | Novel pyrazolopyridine compounds for the treatment of autoimmune disease |
| US12172995B2 (en) | 2018-10-24 | 2024-12-24 | Bristol-Myers Squibb Company | Substituted indole and indazole compounds |
| US11998537B2 (en) | 2018-10-24 | 2024-06-04 | Bristol-Myers Squibb Company | Substituted indole dimer compounds |
| ES2987832T3 (es) | 2019-05-09 | 2024-11-18 | Bristol Myers Squibb Co | Compuestos de benzimidazolona sustituidos |
| WO2021067657A1 (en) * | 2019-10-04 | 2021-04-08 | Bristol-Myers Squibb Company | Substituted carbazole compounds |
| WO2021084022A1 (en) | 2019-10-31 | 2021-05-06 | F. Hoffmann-La Roche Ag | Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune disease |
| CN114728976B (zh) | 2019-11-19 | 2024-08-16 | 豪夫迈·罗氏有限公司 | 用于治疗自身免疫性疾病的氢-1H-吡咯并[1,2-a]吡嗪化合物 |
| US12421252B2 (en) | 2019-11-20 | 2025-09-23 | Hoffmann-La Roche Inc. | Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease |
| IL294527A (en) * | 2020-01-30 | 2022-09-01 | Anima Biotech Inc | Collagen-1 translation inhibitors and methods of their use |
| CN116096717A (zh) | 2020-08-19 | 2023-05-09 | 百时美施贵宝公司 | 咪唑并[1,2-a]吡啶和[1,2,4]三唑并[1,5-a]吡啶衍生物作为TLR9抑制剂用于纤维化的治疗 |
| TW202227409A (zh) | 2020-08-19 | 2022-07-16 | 美商必治妥美雅史谷比公司 | 作為tlr9抑制劑之經取代苯并咪唑 |
| US20250002471A1 (en) * | 2020-12-22 | 2025-01-02 | Gilead Sciences, Inc. | 6-substituted indole compounds |
| CN116783202A (zh) * | 2021-02-09 | 2023-09-19 | 吉利德科学公司 | 噻吩并吡咯化合物 |
| US11661431B2 (en) | 2021-04-16 | 2023-05-30 | Gilead Sciences, Inc. | Thienopyrrole compounds |
| CN117957234A (zh) | 2021-09-10 | 2024-04-30 | 吉利德科学公司 | 噻吩并吡咯化合物 |
| EP4479135A1 (en) * | 2022-02-18 | 2024-12-25 | Bristol-Myers Squibb Company | Substituted imidazopyridinyl compounds useful as inhibitors of tlr9 |
| CN114591339B (zh) * | 2022-05-10 | 2022-08-02 | 上海维申医药有限公司 | 一类Toll样受体抑制剂及其制备和应用 |
| US20250214977A1 (en) * | 2024-01-03 | 2025-07-03 | Kymera Therapeutics, Inc. | Stat6 inhibitors and uses thereof |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
| PL349192A1 (en) | 1998-12-18 | 2002-07-01 | Axys Pharmaceuticals | Protease inhibitors |
| HUP0203323A3 (en) * | 1999-10-19 | 2004-01-28 | Merck & Co Inc | Tyrosine kinase inhibitors and pharmaceutical compositions containing them |
| EP1474425B9 (en) * | 2002-01-07 | 2008-07-02 | Eisai Co., Ltd. | Deazapurines and uses thereof |
| WO2003099206A2 (en) * | 2002-05-21 | 2003-12-04 | Bristol-Myers Squibb Company | Indole compounds useful as impdh inhibitors |
| US20070054921A1 (en) * | 2003-06-05 | 2007-03-08 | Davies Ian W | Substituted indoles and a process for preparing substituted indoles |
| MXPA05013922A (es) | 2003-06-20 | 2006-02-24 | Coley Pharm Group Inc | Antagonistas de receptor tipo toll de molecula pequena. |
| CN101027051A (zh) * | 2004-07-14 | 2007-08-29 | Ptc医疗公司 | 治疗丙型肝炎的方法 |
| EP1850847A2 (en) * | 2005-01-28 | 2007-11-07 | Merck and Co., Inc. | Inhibitors of checkpoint kinases |
| WO2006113458A1 (en) | 2005-04-15 | 2006-10-26 | Bristol-Myers Squibb Company | Heterocyclic inhibitors of protein arginine methyl transferases |
| GB0602178D0 (en) * | 2006-02-03 | 2006-03-15 | Merck Sharp & Dohme | Therapeutic treatment |
| JP2009532501A (ja) | 2006-04-04 | 2009-09-10 | ミリアド ジェネティクス, インコーポレイテッド | 疾患および障害のための化合物 |
| DE102006033109A1 (de) | 2006-07-18 | 2008-01-31 | Grünenthal GmbH | Substituierte Heteroaryl-Derivate |
| US8027888B2 (en) | 2006-08-31 | 2011-09-27 | Experian Interactive Innovation Center, Llc | Online credit card prescreen systems and methods |
| DE602007012133D1 (de) | 2006-12-01 | 2011-03-03 | Andrew Burritt | Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten |
| WO2008152471A1 (en) | 2007-06-12 | 2008-12-18 | Coley Pharmaceutical Group, Inc. | Quinazoline derivative useful as toll-like receptor antagonist |
| WO2009030996A1 (en) | 2007-09-05 | 2009-03-12 | Coley Pharmaceutical Group, Inc. | Triazole compounds as toll-like receptor (tlr) agonists |
| EP2205085A1 (en) * | 2007-09-25 | 2010-07-14 | Merck Sharp & Dohme Corp. | 2-aryl or heteroaryl indole derivatives |
| WO2010036905A1 (en) * | 2008-09-26 | 2010-04-01 | Eisai R & D Management Co., Ltd. | Benzoxazole compounds and methods of use |
| EP2340243B1 (en) | 2008-10-17 | 2014-10-08 | Boehringer Ingelheim International GmbH | Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| TWI462920B (zh) | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | 用於治療退化性及發炎疾病之新穎化合物 |
| WO2011009015A1 (en) | 2009-07-16 | 2011-01-20 | Mallinckrodt Inc. | (+) - morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| CN102574788A (zh) | 2009-09-24 | 2012-07-11 | 弗·哈夫曼-拉罗切有限公司 | 作为crac调节剂的吲哚衍生物 |
| MX2012004792A (es) | 2009-10-22 | 2013-02-01 | Vertex Pharma | Composiciones para el tratamiento de fibrosis quistica y otras enfermedades cronicas. |
| US9241991B2 (en) | 2010-10-21 | 2016-01-26 | The Brigham And Women's Hospital, Inc. | Agents, compositions, and methods for treating pruritus and related skin conditions |
| CN103562186B (zh) | 2011-01-12 | 2017-02-15 | 帆德制药股份有限公司 | 作为toll样受体调节剂的取代的苯并氮杂卓 |
| BR112013017947A2 (pt) | 2011-01-12 | 2018-12-18 | Array Biopharma Inc | benzoazepinas substituídas como moduladores de receptor toll-like |
| AU2012262021B2 (en) | 2011-06-01 | 2016-07-28 | Janus Biotherapeutics, Inc. | Novel immune system modulators |
| WO2012167046A1 (en) | 2011-06-01 | 2012-12-06 | Janus Biotherapeutics, Inc. | Novel immune system modulators |
| AU2012267556B9 (en) | 2011-06-09 | 2017-05-11 | Rhizen Pharmaceuticals Sa | Novel compounds as modulators of GPR-119 |
| WO2013010904A1 (en) | 2011-07-15 | 2013-01-24 | Janssen Pharmaceuticals, Inc. | Novel substituted indole derivatives as gamma secretase modulators |
| CA2850932A1 (en) | 2011-10-04 | 2013-04-11 | Janus Biotherapeutics, Inc. | Novel imidazole quinoline-based immune system modulators |
| JP6184423B2 (ja) | 2012-05-18 | 2017-08-23 | 大日本住友製薬株式会社 | カルボン酸化合物 |
| JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
| EP2738172A1 (en) | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
| RS59911B1 (sr) | 2013-10-14 | 2020-03-31 | Eisai R&D Man Co Ltd | Selektivno supstituisana jedinjenja hinolina |
| JP2016540013A (ja) | 2013-12-13 | 2016-12-22 | 武田薬品工業株式会社 | Tlr阻害剤としてのピロロ[3,2−c]ピリジン誘導体 |
| PL3190113T3 (pl) | 2014-08-15 | 2021-10-25 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Związki pirolopirymidynowe stosowane jako agonista TLR7 |
| WO2016029077A1 (en) | 2014-08-22 | 2016-02-25 | Janus Biotherapeutics, Inc. | Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof |
| EP3072891A1 (en) | 2015-03-24 | 2016-09-28 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | New Toll-Like Receptor 9 Antagonists |
| US10071079B2 (en) * | 2016-06-29 | 2018-09-11 | Bristol-Myers Squibb Company | [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds |
| CA3031675A1 (en) * | 2016-07-30 | 2018-02-08 | Bristol-Myers Squibb Company | Dimethoxyphenyl substituted indole compounds as tlr7, tlr8 or tlr9 inhibitors |
| ES2902504T3 (es) * | 2016-09-09 | 2022-03-28 | Bristol Myers Squibb Co | Compuestos de indol sustituidos con piridilo |
| WO2019028301A1 (en) | 2017-08-04 | 2019-02-07 | Bristol-Myers Squibb Company | INDOLE COMPOUNDS SUBSTITUTED WITH [1,2,4] TRIAZOLO [4,3-A] PYRIDINYL |
| ES2909401T3 (es) | 2017-08-04 | 2022-05-06 | Bristol Myers Squibb Co | Compuestos de indol sustituidos útiles como inhibidores de TLR7/8/9 |
| EP3710440B1 (en) * | 2017-11-14 | 2023-04-05 | Bristol-Myers Squibb Company | Substituted indole compounds |
-
2018
- 2018-12-18 CN CN201880081676.4A patent/CN111491930B/zh active Active
- 2018-12-18 AU AU2018390820A patent/AU2018390820A1/en not_active Abandoned
- 2018-12-18 SG SG11202005696YA patent/SG11202005696YA/en unknown
- 2018-12-18 MX MX2020005462A patent/MX2020005462A/es unknown
- 2018-12-18 US US16/955,097 patent/US11878975B2/en active Active
- 2018-12-18 EP EP18830687.2A patent/EP3728225B1/en active Active
- 2018-12-18 EA EA202091474A patent/EA202091474A1/ru unknown
- 2018-12-18 WO PCT/US2018/066149 patent/WO2019126113A1/en not_active Ceased
- 2018-12-18 BR BR112020012084-7A patent/BR112020012084A2/pt not_active Application Discontinuation
- 2018-12-18 KR KR1020207020558A patent/KR102742178B1/ko active Active
- 2018-12-18 ES ES18830687T patent/ES2932361T3/es active Active
- 2018-12-18 JP JP2020534224A patent/JP7291145B2/ja active Active
- 2018-12-18 CA CA3085590A patent/CA3085590A1/en active Pending
-
2020
- 2020-06-14 IL IL275356A patent/IL275356A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021506889A5 (enExample) | ||
| JP2021506923A5 (enExample) | ||
| JP2021506858A5 (enExample) | ||
| US8829185B2 (en) | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
| RU2473549C2 (ru) | Пиримидиновые соединения, композиции и способы применения | |
| JP4638355B2 (ja) | チアゾール誘導体 | |
| CA2610888A1 (en) | Inhibitors of akt activity | |
| JP2014506929A5 (enExample) | ||
| JP2013522334A (ja) | ピロロピラジンのキナーゼ阻害剤 | |
| US10214537B2 (en) | Bicyclic heteroaryl amine compounds | |
| JPWO2020005873A5 (enExample) | ||
| JP2016525092A5 (enExample) | ||
| JP2015522002A5 (enExample) | ||
| JP2012532931A5 (enExample) | ||
| JP2019535664A5 (enExample) | ||
| JP2012532152A5 (enExample) | ||
| JP2010510319A5 (enExample) | ||
| JP2021506816A5 (enExample) | ||
| RU2013142648A (ru) | 6,5-гетероцикл пропаргиловые спирты и их применения | |
| CA2671614A1 (en) | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
| GB2609879A (en) | Antagonists of the adenosine A2a receptor | |
| RU2015144386A (ru) | Циклоалкилнитрилпиразолопиридоны в качестве ингибиторов янус-киназы | |
| US7928098B2 (en) | Therapeutic and/or preventive agents for a sleep disorder | |
| JPWO2020005877A5 (enExample) | ||
| IL310330A (en) | Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling |